Document Actions

Events

Click on a day in the calender on the right to see an event by date. Members can add an event by clicking on the 'add conference' link in the top bar and completing the form. After you save your event, edit it until you are happy with the result. When you are ready to publish the event to the site, click on the 'state:' menu in the top bar and select submit. A ChemWeb editor will review the event and post significant events to the site within 24 hours. If you are interested in sponsoring your event, contact us using the 'Contact Us' link at the bottom of the page.

Encouraging Development of Therapeutics for Neglected Diseases by Robert Black — last modified 02-26-10 01:55 AM: There has been a significant increase in the level of activity and attention being paid to the development of therapeutics for neglected diseases over the past five years, but there are still considerable challenges in the road ahead. Diseases in the developed world receive a disproportional investment because of the commercial potential from large markets and the ability to pay for such treatment. Innovative approaches are being developed to stimulate interest and provide incentives for companies and other researchers to work on finding new therapeutics for diseases prevalent in developing countries. Almost all work in this field will be based on collaborations of one type or another, during discovery, drug evaluation or, when successful, delivery of treatments. This forum is designed to bring together many of the major stakeholders addressing these problems, in order to examine and discuss strategies and best practices for solving the major challenges that prevent faster and more effective solutions.
Beyond Sequencing by Robert Black — last modified 02-22-10 10:23 AM: Purchasing your next-generation sequencing (NGS) platform(s) was a major decision. Now that you have purchased a platform, how do you maximize the greatest potential for your investment? Realizing this potential requires efficient workflow strategies, careful experimental design, comprehensive targeted enrichment technologies, data analysis, management, and integration, in addition to maintaining your platform and people management all at maximum production. The central theme at Cambridge Healthtech Institute’s Inaugural Beyond Sequencing: Strategies for Success is efficient use of your NGS platform. Sessions will focus on common bottlenecks, case studies, real-world experiences and solutions from experienced users. Additionally, two emerging applications for metagenomics and deep sequencing for cancer will be showcased, as well as the latest results in the 1,000 Genomes Project.
World Pharmaceutical Congress by Robert Black — last modified 02-22-10 10:23 AM: Conference Program Include: Evaluating Novel Technologies for Cell Based Screening, Monitoring Cardiotoxicity and Drug Safety, Targeting Pain with Novel Therapeutics, New Tools for Detecting Nephrotoxicity, Successful Targeting of Alzheimer's Disease, Pharmacology Driven Assays for Current Targets, Integrated in vivo Molecular Imaging in Drug Discovery & Development, Early Assessments for Predicting Hepatotoxicity
Biomarker World Congress by Robert Black — last modified 02-22-10 10:23 AM: Over 400 thought leaders from 200+ organizations, representing 21 countries, gathered at the Biomarker World Congress 2009 (May 27-29 in Philadelphia) to discuss the biomarker impact on Personalized Medicine, Clinical Pharmacology, Translational Medicine, Molecular Diagnostics, Safety Assessment, Clinical Trials, Assay Development, Go/No-Go Decision Making and Oncology in Drug & Diagnostics. The level of energy and participation reflected the booming interest in this field. Comprehensive Coverage of Biomarkers in: Personalized Medicine, Clinical Pharmacology, Translational Medicine, Molecular Diagnostics, Safety Assessment, Clinical Trials, Assay Development, Biomarker Qualification, Oncology Drugs & Diagnostics
Drug Discovery Chemistry by Robert Black — last modified 02-22-10 10:24 AM: Conference Programs Include: Resistance is Futile: The Challenge of Antibacterial Drug, Development Integrating Chemistry and Biology, Fragment-Based Drug Discovery, Anti-inflammatories: Small Molecule Approaches, HCV Drug Discovery, Directly targeting viral and host proteins necessary for HCV infection, Kinase Inhibitor Chemistry – Charting the Chemical Space, Protein-Protein Interactions as Drug Targets
Future Diagnostics by Robert Black — last modified 02-22-10 10:24 AM: This new forum focused on future molecular diagnostics will highlight innovative platforms, novel chemistry, and latest approaches to developing sensitive detection of analytes. This meeting is designed to be the premier think tank for building future diagnostics platforms and a forum for presenting new papers. There will be ample discussion around moving novel diagnostics to the clinic and strategies for success.
Collaborative Innovation in Biomedicine by Robert Black — last modified 02-22-10 10:24 AM: The biomedical industry is under enormous pressure to produce faster results, while also finding ways to reduce costs. Examples abound in one industry after another of how researchers have gained tremendous advantages by collaborating on pre-competitive efforts, but such efforts have been limited in biomedical research, where researchers often find it difficult to openly share data within their own organization, much less with competitors. Working together, sharing information, and data sets and costs, all have significant potential for improved performance, but only when such efforts make use of best practices and lessons learned from existing projects. Cambridge Healthtech Institute’s Collaborative Innovation in Biomedicine aims to bring together a number of experts with practical experience in organizing, managing, funding, and getting results from such projects. While there are real challenges with shared resources, IP protection, differing goals, and finding ways to equalize value contributions and benefits gains, some of the biggest challenges are based on firmly held beliefs about the risks of working together and narrow conceptions of what really constitute pre-competitive space. A key goal of the program is to provide attendees with a number of key strategies for identifying when and how collaborative innovation can and should be encouraged, as well as when such efforts are less likely to produce useful results.
PEGS: the essential protein engineering summit by Robert Black — last modified 02-22-10 10:25 AM: Conference Programs Include: Phage and Yeast Display of Antibodies and Proteins, Engineering Antibodies, Antibody Optimization, Difficult to Express Proteins, Pre-Clinical/Clinical Development of Therapeutic Antibodies, Revival of Bispecific Antibodies: The Way Forward?, Immunogenicity of Therapeutic Biologics, Protein Aggregation in Biopharmaceutical Products, Bioanalytical Challenges for Optimizing Protein Therapeutics
Combination Drug Therapies by Robert Black — last modified 02-22-10 10:25 AM: Fixed-Dose and Co-Packaged Combinations provide novel business opportunities for companies to leverage their existing portfolio of products and intellectual property in addition to providing avenues for strategic partnership with other companies. However, they also offer unique development, regulatory, and commercial challenges. This conference will focus on the practical interplay between combination therapy forefront research, development challenges, and commercial and partnering strategies, as well as the implications for successful market realization.
Biopharmaceutical Change Control by Robert Black — last modified 02-22-10 10:25 AM: In the life-cycle of biopharmaceuticals, manufacturing change is unavoidable. Owing to the complex nature of the biopharmaceutical product, physicochemical and functional changes occur which can affect both safety and efficacy. This three-track event looks at manufacturing change and its potential consequences, and industry experiences with handling this and harnessing it to advantage. Conferences Include: Protein Scale-Up, Process Change & Technology Transfer, Post-translational Modifications, Comparability at all Stages of Development
Encouraging Development of Therapeutics for Neglected Diseases by Robert Black — last modified 02-22-10 10:27 AM: There has been a significant increase in the level of activity and attention being paid to the development of therapeutics for neglected diseases over the past five years, but there are still considerable challenges in the road ahead. Diseases in the developed world receive a disproportional investment because of the commercial potential from large markets and the ability to pay for such treatment. Innovative approaches are being developed to stimulate interest and provide incentives for companies and other researchers to work on finding new therapeutics for diseases prevalent in developing countries. Almost all work in this field will be based on collaborations of one type or another, during discovery, drug evaluation or, when successful, delivery of treatments. This forum is designed to bring together many of the major stakeholders addressing these problems, in order to examine and discuss strategies and best practices for solving the major challenges that prevent faster and more effective solutions.
Polymers in Medicine 2012 by Josef Juza — last modified 02-22-10 10:21 AM: The 77th Prague Meetings on Macromolecules: Polymers in Medicine will focus on the latest innovative development in drug delivery systems. Meeting brings together multi-disciplinary researchers from both academia and industry in the areas of pharmaceutics, polymer and materials science, imaging, cell and molecular biology, genetic, and medicine.
Contemporary Ways to Tailor-made Polymers by Josef Juza — last modified 02-22-10 10:28 AM: The Symposium is the 74th in the series of annual Prague Meetings on Macromolecules, the first of which was held in 1967. The Meetings are themed events, getting together people engaged in basic as well as applied research in certain field of polymer science. Thus, the announced conference addresses researchers dealing with all types of polymer synthesis, their characterization and applications, including design of tailored polymer materials for various use in technical and biological applications.
10th Glass Stress Summer School by chemweb — last modified 02-08-10 06:18 AM: 17-18 June, 2010 House of Cybernetics, Tallinn, Estonia Intended Audience Engineers, technologists and scientists from glass industry and glass research laboratories who wish to acquire contemporary photoelastic methods for residual stress measurement in glass products of any shape. The participants may bring to Summer School samples they want to measure stresses in. Course Outline Basic elasticity, basic photoelasticity, integrated photoelasticity, stress field tomography, scattered light photoelasticity, automatic polariscope AP-07 for residual stress measurement in glass articles of complicated shape, scattered light polariscope SCALP-04 for thickness stress measurement in plates, immersion technique, software for stress calculation using measurement data, practical measurement of residual stress in tempered and annealed drinking glasses, bottles, CRT bulb panels and neck tubes, optical fibre performs, architectural glass panels and automotive glazing, etc.
9th International Symposium on Functional π-Electron Systems by chemweb — last modified 01-29-10 05:59 AM: F-π-9 is expected to attract up to 500 participants from all over the world to discuss their new research and results in the context of conjugated polymer/oligomer synthesis, organic semiconductor materials, photovoltaic and electroactive materials and devices, graphene, functional π-systems for therapeutic applications and more. Six plenary speakers will present their latest research along with 35 invited speakers. The program will also include some 84 contributed talks and three poster sessions, which will allow students and others to highlight their recent work.
Frontiers in the Simulation of Macromolecules by chemweb — last modified 01-29-10 05:49 AM: The simulation of biological function has advanced enormously since the early attempts to use computers to understand how biological systems work. The emergence of effective approaches, the increase in computational power, and a rapid expansion of the field have allowed for the simulation of ever more challenging biological problems. A symposium marking both the landmarks and the current frontiers in the field of molecular simulation will be held at the University of Southern California between the 12th and 14th of November, 2010. USC is located in the heart of Los Angeles, just 10 minutes drive from Downtown Los Angeles, and about 30 minutes drive from the Pacific Ocean. The current list of invited speakers includes Rudy Marcus, Michael Levitt and Barry Honig, amongst others. Additionally, there will be (limited) possibility for oral presentations, as well as the possibility of poster presentations for conference attendees. Detailed information about our symposium can be found at our web site.
Third European Workshop in Drug Synthesis by chemweb — last modified 01-29-10 04:29 AM: The workshop will consist of lectures in the morning and applications of techniques and methodologies for the drug design in the afternoon (i.e. virtual screening, softwares for the synthesis, instrument description and exhibition, exercises etc). III EWDSy will feature more than 20 well known researchers from the University and from the Pharmaceutical Industry, including directors of research, working with a maximum number of 65 workshop participants. Some posters will be selected for a short presentation.
International Conference for Young Chemists 2010 by chemweb — last modified 01-29-10 04:07 AM: The Penang International Conference for Young Chemists (ICYC 2010) is a biennial conference organized specifically for young chemist by the postgraduate students of School of Chemical Sciences, Universiti Sains Malaysia, Penang. Due to the overwhelming response from participants and speakers from all over the world for ICYC 2006 and 2008, School of Chemical Sciences is continuing this unique biennial tradition for the year 2010.
17th International Symposium on Homogeneous Catalysis by chemweb — last modified 01-29-10 03:51 AM: The symposium programme will cover all areas of homogeneous and organometallic catalysis and focus on recent research achievements and ideas on new catalytic reactions, well-known processes occurring in the presence of new effective homogeneous and immobilized catalysts, new mechanisms of catalysis. Particular emphasis will be put on sustainable catalytic processes of key importance in organic synthesis (fine and specialty chemicals, pharmaceuticals) as well as in synthesis of polymers and precursors of advanced materials.
The Organic Reaction Catalysis Society 23rd Conference by chemweb — last modified 01-29-10 02:18 AM: The Organic Reaction catalysis Society seeks to advance the practical application of catalysis . The conference will have symposia on C-C coupling, Chemicals from Biorenewable Feedstocks, and hydrogenation. Matthias Beller, and Hans-Ulrich Blaser will receive awards and are featured speakers. Registration is online at www.orcs.org
Balticum Organicum Syntheticum 2010 by Jaan Pesti — last modified 01-18-10 02:56 AM: Balticum Organicum Syntheticum 2010 (BOS) is the 6th conference of this Baltic chemical conference series, rotating between the Baltic capitals every two years and highlights a mixture of academic and industrial Plenary Speakers presenting Lectures on the topics of organic, synthetic, pharmaceutical, process, catalytic and organometallic chemistry. The conference is restricted to 300 participants to assure all get to interact with the speakers, which is encouraged by a reception and banquet. Balts and students are particularly encouraged to attend. Two poster sessions are held.
Polymorphism & Crystallisation by Sue Parsons — last modified 12-10-09 03:39 PM: This 2-day conference focuses on case studies from process chemists and engineers on chemical development issues, which impact the ability to routinely manufacture chosen crystalline forms. Experts on polymorphism and crystallisation also give lectures on troubleshooting and problem solving, as well as giving insights into new techniques of value for the future.
Process Analytical Technologies (PAT) in Organic Process R&D by Sue Parsons — last modified 12-10-09 03:38 PM: This is the only Process Analytical Technology (PAT) Conference dedicated to process chemistry and organic synthesis. It emphasises the science and technology associated with the synthesis and manufacture of active pharmaceutical ingredients and showcases the use of PAT as a tool for increasing process understanding, robustness, reproducibility and efficiency in API manufacture, both in development and commercial production.
Modern Synthetic Methods & Chiral Europe by Sue Parsons — last modified 12-10-09 03:38 PM: This 3-day conference provides discovery, medicinal and process chemists with a forum to meet with academia to discuss novel organic synthetic methods useful in research and development. We focus on key transformations, e.g. carbon-carbon bond forming reactions, oxidation and reduction, formation and reactions of heterocyclic molecules and biotransformations. We also focus on chiral technology, including: asymmetric chemocatalysis, biocatalysis, new analytical and separation techniques, and the development of important chiral pharmaceuticals.
XXV International Symposium on Physico-Chemical Methods of Separation by Izabela Koter — last modified 11-18-09 02:18 AM: The main objective of “Ars Separatoria 2010” is to present and discuss the latest achievements in separation, isolation, purification methods and processes applied in chemistry, industry and environmental protection. The topics of Symposium: membrane separation techniques, phase equilibria, extraction, flotation, chromatography
Third International Conference on Semiconductor Photochemistry by chemweb — last modified 11-13-09 06:32 AM: The aim of the conference is to cover recent developments in the area of semiconductor photochemistry. The topics will encompass: * Solar to Electricity conversion (DSSCs) and Tandem Cells * Solar to Chemical Energy conversion (such as water splitting and CO2 reduction) * Photosterilisation * Organic Photosynthesis * Air and Water Remediation * Self Cleaning Surfaces
EUCHEM Conference on Stereochemistry The 45th ‘Bürgenstock Conference’ by chemweb — last modified 11-13-09 06:13 AM: The ‘EUCHEM Conference on Stereochemistry’, better known as ‘Bürgenstock Conference’, is an outstanding international chemistry meeting of high scientific quality, with an optimal setting for intense inter-disciplinary discussion. Stereochemistry is the principle underlying our understanding of the processes of life and the properties of matter at the molecular level. It is a key element not only in all chemical disciplines, but also in modern molecular biology, molecular medicine, biophysics, and material design. Accordingly, the ‘Bürgenstock Conference’ has grown over the years into a multi-disciplinary conference where frontier science is being discussed. Lectures cover many areas of chemistry and relevant highlights from neighboring disciplines..
BIT's 1st Annual World Congress of Catalytic Asymmetric Synthesis by chemweb — last modified 11-11-09 06:52 AM: Official Information: The 1st Annual World Congress of Catalytic Asymmetric Synthesis-2010 (WCCAS-2010) will be held from May 19 to May 21, 2010 in Beijing, China, with a theme of " Create Bioactive Molecules Green and Economically ". This is a focused event on Catalytic Asymmetric Synthesis, it aims to stimulate interactions among academia, industry and researchers in this field; to exchange up-to-the-minutes information and promote their novel technologies. On behalf of the organizing committee of WCCAS-2010, we cordially invite you to participate in this international event. Scope WCCAS-2010 is expected to greatly contribute to the promotion of new concepts for the development of efficient methodologies for catalytic asymmetric synthesis and its practical applications. The topics will reflect this general theme, placing emphasis on aspects that are common to all areas of catalytic asymmetric synthesis and the type of reaction involved: * Novel Technologies for Catalytic Asymmetric Synthesis * Organometallic Chiral Catalysts in Asymmetric Transformations * Enantioselective/ Diastereoselective Organocatalysis * Applications of Catalytic Asymmetric Synthesis * Biocatalysis for Asymmetric Transformations * Business Development for High Value Chiral Molecules Scientific Program The scientific program will consist of plenary and keynote lectures, approximately 30 sessions, exhibition and poster sessions. More program information can be found at: http://www.bitlifesciences.com/wccas2010/program.asp Location The capital city of the People's Republic of China, Beijing is a fast-growing, dynamic metropolis that, while courting foreign businesses and visitors, maintains a firm grip on its rich cultural heritage. Beijing made history in 2008 with the first Olympic Games ever to be held in China. The conference will be held in Beijing International Convention Center (BICC) which is located within the magnificent Asian Games Village. It is one of the Chinese biggest facilities specifically designed for conferences and exhibitions, comprising 50 conference halls and meeting rooms equipped to serve a wide variety of purposes with the capacity from 10 up to 2500 people. We look forward to seeing you in next May in Beijing, China.
InformEx 2010 by chemweb — last modified 11-04-09 07:39 AM: About Informex For over 25 years Informex has been North America’s leading trade fair for companies dedicated to higher value chemistry. The show began in 1983 with a need to support companies that wanted new ways to produce cutting-edge chemicals, more efficiently, and with greater reliance on the expertise of fine and specialty chemical producers. Today’s pharmaceutical innovators, agrochemical product makers, electronic materials producers and other manufacturers that come to Informex find what they need for business success, mainly new ideas that make a difference, and qualified companies with production assets that can make those ideas a reality. Most will remember the first two decades of the show for its outsourcing component. Yet with the vast majority of technical challenges spotlighted in the media either beginning or ending at the molecular level, the next 25 may well be remembered as the era of Intellectual Alliances. With the easy technology breakthroughs accounted for in patent literature, companies may work more in alliances to achieve the next big thing. We already see this in major global industries like aircraft manufacturing, and with small start-up companies in search of economically viable renewable energy technologies. So to will the chemical industry and allied trades work more on a collaborative basis going forward to achieve major technical advances in areas like green chemistry, and sustainability.
12th Belgian Organic Synthesis Symposium (BOSSXII) by chemweb — last modified 11-04-09 07:29 AM: The BOSS-conference is a unique international symposium as, apart from invited lectures delivered by established organic chemists as well as younger rising stars, two prestigious events are associated with it: a lecture delivered by the recipient of a “Prize for Creativity in Organic Synthesis”, and a one-day course on a specific topic in organic synthesis by an eminent lecturer. The conference covers a broad range of timely subjects in the field of organic chemistry.
XXIII IUPAC Symposium on Photochemistry by chemweb — last modified 11-04-09 07:21 AM: The symposium will provide a framework for presentation and discussion of ideas and information on the interaction of light and matter drawn from the following areas: * Organic and inorganic photochemistry from a synthetic and mechanistic point of view * Solar energy conversion * Materials science and engineering * Supramolecular chemistry and nanotechnology * Photobiology and biophysics * Photonics and imaging * Spectroscopy and instrumentation * Photochromism * Industrial applications of photochemistry and photophysics.
The 25th International Carbohydrate Symposium by chemweb — last modified 10-30-09 07:44 AM: The International Carbohydrate Symposium (ICS) is the most important event in carbohydrate chemistry and biochemistry, biennially organized under the auspices of the International Carbohydrate Organization (ICO). Since the first meeting held in1960 (Gif-sur-Yvette, France), ICS is going to enjoy its 50th anniversary in 2010. Reflecting rapid expansion of the field, the scope of the symposium will be broad. It will cover diverse aspects of glycosciences, which include chemical and enzymatic synthesis, chemical biology, glycobiology, therapeutics, structural biology, and industrial applications.
18th International Conference on Organic Synthesis by chemweb — last modified 10-30-09 07:01 AM: The structure of the meeting will be accordance with the tradition that has emerged for the ICOS series of conferences, with lectures including the Thieme-IUPAC Prize award lecture, poster sessions, and a Wednesday afternoon conference trip. Within this framework the program development is making good progress in cooperation with an excellent International Advisory Board, and a number of outstanding speakers have already accepted the invitation to come.
Eighth International Conference on Low Temperature Chemistry by chemweb — last modified 10-30-09 04:08 AM: The ICLTC is an international conference dedicated to the research of chemical and physical phenomena and processes undergoing at cold temperatures. The previous conferences have taken place in Moscow, Russia (1994), Kansas, USA (1996),Nagoya, Japan (1999), Jyvaskyla, Finland (2002), Berlin, Germany (2004), Chernogolovka, Russia (2006), and Helsinki, Finland (2008)
3rd EuCheMS Chemistry Congress 2010 by chemweb — last modified 10-30-09 03:35 AM: The 3rd EuCheMS Chemistry Congress in Nürnberg (Nuremberg) 2010 will present the latest research in the core topic areas of chemistry, feature multidisciplinary programming, and highlight chemistry‘s impact on society. The Congress will bring together chemical and molecular scientists from industry, academia and government institutions across Europe and from around the world. The vendor exhibition will include leading companies showing their latest innovations in chemistry and related fields. This Congress is organised under the auspices of the EuCheMS, the European Association for Chemical and Molecular Sciences, which has 50 member societies in total representing 150.000 individual chemists; the German Chemical Society (Gesellschaft Deutscher Chemiker, GDCh) is the host society for the Congress.
Biocatalysis Conference by chemweb — last modified 10-30-09 03:22 AM: This conference will cover recent developments in biocatalysis in both academe and industry including topics such as enzyme discovery, directed evolution of enzymes, scale-up of biocatalytic processes, novel screening methods, metagenomics, pathway engineering and other areas of related research. The conference will be of interest to those working in the fields of organic chemistry, microbiology, biocatalysis and bioprocess development.
Ultrafast Time-Resolved Spectroscopy by chemweb — last modified 10-30-09 03:03 AM: Ultrafast Systems is excited to announce its 1st annual Ultrafast Spectroscopy workshop. This course is intended to give the participants an in-depth introduction to the principles of time-resolved fluorescence and absorption spectroscopy. The expected participants will be scientists who are currently using or intend to use ultrafast spectroscopy in their research. While most attendees will have some knowledge of time-resolved spectroscopy, other participants from different research areas will have an opportunity to get a powerful introduction to this exciting and growing field.
International Conference On Nanoscience and Nanotechnology (ICONN 2010) by chemweb — last modified 10-30-09 02:43 AM: ICONN 2010 is an initiative to bring about challenging leads, enhancing research skills and edifying insights in field of Nanoscience and technology. This gives an opportunity to researchers and scientists across the globe to improve the current state of technology which would help in the betterment of mankind. ICONN 2010 will lead to a repository of scientific data which can be shared by both Indians and scientists abroad. Apart from that, this conference is greatly indebted and dedicated to the silver jubilee celebrations of SRM University 2009-2010.
Enzymology and ecology of the nitrogen cycle by chemweb — last modified 10-30-09 02:27 AM: Each September PhD students and young scientists from across Europe gather to present their data at the annual European Nitrogen Cycle meeting. In 2010 and with the support of the Biochemical Society the 15th meeting in the series will also include a number of contributions from invited speakers. Every young participant attending the meeting is encouraged to present their work, preferably orally but at least as a poster. The meeting will be held in Lucas House, Birmingham University, and will be fully residential. Scientific sessions will begin on the afternoon of 15 September with a Plenary Lecture, and will be followed by twenty short presentations by PhD students and post-doctoral research fellows interspersed with eight slightly longer lectures from internationally recognized senior scientists. The scope of the meeting will span from ecology to microbial physiology, biochemistry, molecular genetics and gene regulation. It will cover all aspects of the Biological Nitrogen Cycle: nitrification; denitrification; respiratory reduction of nitrate to ammonia; annamox; the generation and removal of reactive nitrogen species; and the effects on climate of the Greenhouse gases nitric oxide, nitrogen dioxide and especially nitrous oxide.
14th International Symposium on Solubility Phenomena & Related Equilibrium Processes by chemweb — last modified 10-30-09 02:05 AM: Traditionally the symposium deals with all aspects of solubility: in and between solids, liquids and gases; new experimental methods for investigation of solubility phenomena, new analytical techniques, new experimental data, prediction of solubilities and phase equilibria by thermodynamic and molecular modelling, correlation to molecular structure, thermodynamic data bases, application of solubility data and phase equilibria in industry, for protection of environment and in geochemistry.
20th International Conference on Physical Organic Chemistry by chemweb — last modified 10-30-09 01:58 AM: The 20th International Conference on Physical Organic Chemistry (ICPOC-20) will be held in Busan, Korea on 24-31 August 2010. You are cordially invited to the conference, which will cover the whole subject for the fields of structure-activity relations, structure-reactivity relations, structure-physical property relationships, spectral properties, substituent effects, solvent and medium effects, weak molecular interactions, macromolecular systems and molecular modeling.
International Scientific Conference on Pervaporation and Vapor Permeation by Izabela Koter — last modified 10-30-09 01:18 AM: Recognizing increasing needs in new materials and applications of pervaporation, vapor permeation and membrane distillation processes, Membrane Separation Processes Research Group from Nicolaus Copernicus University (Toruń, Poland) decided to organize in April 2010 International Conference on Pervaporation and Vapor Permeation. Conference Topics to be Covered: 1. Fundamentals of pervaporation, vapor permeation and membrane distillation processes. 2. New membrane materials (polymeric/inorganic). 3. Applications: · dehydration, removal of organics from water, organic-organic separation; · large scale applications, hybrid industrial operations including PV/VP; · membrane distillation; · small scale and niche applications. 4. Environmental impact and economics of industrial plants.
Organic Process Research & Development by Sue Parsons — last modified 10-28-09 07:15 AM: This 3-day conference brings together chemists and engineers from all parts of the world to discuss issues related to synthetic route design, development and optimisation and the scale-up of these processes. The invited speakers have been selected to emphasise their company’s approach to these issues with detailed case studies.
The Scale-Up of Chemical Processes by Sue Parsons — last modified 10-28-09 07:14 AM: This is the major international forum for the discussion of all technical aspects of scale-up at the chemistry/chemical engineering interface. Topics include: the scale up of batch and semi-batch processes, continuous processing and reaction engineering, microreactor technology, safety and thermochemistry, scale up of potentially hazardous chemistry, green chemistry, quality assurance and regulatory concerns, solid form control (crystallisation and polymorphism), separation and purification techniques, and new technologies and equipment for large scale manufacture.
Industrial Green Chemistry Workshop (IGCW-2009) by chemweb — last modified 10-26-09 08:04 AM: IGCW is a first Industrial event where 300-400 stakeholders of Chemical Industries will come together to explore the possibilities of industrializing Green Chemistry & Green Engineering technologies to their products, services & streams.
German Conference on Chemoinformatics - 23. CIC-Workshop 2009 by chemweb — last modified 10-26-09 07:58 AM: In the spirit of previous meetings organised by the CIC-division the topics of our international symposium will span a wide range of contributions related to chemoinformatics and to chemical information. We wish to attract both industrial and academic scientists in this field. The scientific programme will include plenary lectures as well as presentation of posters, projects and software.
Pharma-Bio-Med 2009 by chemweb — last modified 10-21-09 05:02 AM: Best practices in Pharmaceutical, Biomedical, Biotechnology, Medical and Competitor Information The Pharma-Bio-Med 2009 One-Day Meeting is being held on Monday 9th November 2009 in Frankfurt, Germany. Pharma-Bio-Med is the premier forum in Europe specifically geared to Information Professionals within the pharmaceutical, biotechnology, biomedical, medical and health sciences industries.
Second Regional Symposium on Electrochemistry : : South-East Europe by Aleksandar Dekanski — last modified 09-21-09 01:59 AM
5th Lithium Mobile Power Conference by chemweb — last modified 07-13-09 08:37 AM: Drawing upon ten years of tracking developments in lithium battery and fuel cell research, Lithium Mobile Power will guide delegates from technology and materials development, through device packaging and integration, to applications in a mobile power marketplace by exploring the following important topics: • Li-ion batteries for PHEV, HEV, and EV - issues and solutions • Revolutionizing Li-ion batteries for portable and consumer products • Materials challenges - electrodes & electrolyte • Safety, testing, performance • System design & integration
The 25th China Plant Protection Information Exchange &Pesticide and Sprayer Facilities Trade Fair by David Xiao — last modified 07-13-09 08:27 AM: The 25th China Plant Protection Information Exchange &Pesticide and Sprayer Facilities Trade Fair((hereinafter as CPIET) is an annual grochemical symposium and exhibition sponsored by the National Agro-Tech Extension & Service Center (NATESC) of Ministry of Agricultural of China，and organzied by The Vegetational Protection Central Station of Shandong Province ，CPIET 2009 wil be held in Jinan International Convention & Exhibition Center from November 15-17, 2009 . The fair has been successfully held 24 sessions since 1985. Through more than 20 years development, CPIET has become the first grand fair with biggest scale, most popular and far-reaching influence in China pesticide and sprayer facilities industry . The exhibition scale will be reached more than 50000 square meters, over 1000 exhibitors from home and abroad will attnd our fair , and more than 120,000 visitors will come to CPIET . I would be very pleased to take this oportunity to invite you to attend this fair 。Welcome to Jinan ,China . We are looking forward to your early reply . For more information ,please log on our offical website : www.zgzbsjh.com ( To be renewed ) or contact us by : Tel: +86-531-8801 6738 Fax: +86-531-8801 7398、8801 7698 MSN: Tianfu28@yahoo.com.cn Email: Tianfu28@yahoo.com.cn Sincerely yours Mr David Xiao
5th Lithium Mobile Power by David Mello — last modified 07-02-09 11:19 AM: Significant innovations have propelled lithium ion battery technology to a position in the marketplace far exceeding earlier market survey expectations. From a vast array of portable applications, to micro medical devices, to high-power automotive, these breakthroughs have paved the way for an emerging market with unlimited potential. Lithium Mobile Power will guide attendees from technology and materials development, through device packaging and integration, to applications in a mobile power marketplace by exploring the following topics: • Li-ion batteries for PHEV, HEV, and EV - issues and solutions, • Revolutionizing Li-ion batteries for portable and consumer products, • Materials challenges - electrodes & electrolyte, • Safety, testing, performance, • System design & integration
Polymer Chemistry: Principles and Practice by Daniel Fishman — last modified 06-30-09 07:30 AM: This six-day course is taught by five Virginia Tech professors and is designed for all education levels. Students can expect to learn about polymer synthesis, molecular weight determination, characterization of rheological and viscoelastic behavior; gain a better understanding of polymer structure and morphology, and mechanical testing; study elastomers, plastics, and fibers; learn from practical examples from fields of adhesion and composites; and understand the measurement of properties of polymers, which are then discussed as functions of chemical composition, molecular weight, topology, morphology, etc.
Polymer Chemistry: Principles and Practice by Daniel Fishman — last modified 06-30-09 07:22 AM: This six-day course is taught by five Virginia Tech professors and is designed for all education levels. Students can expect to learn about polymer synthesis, molecular weight determination, characterization of rheological and viscoelastic behavior; gain a better understanding of polymer structure and morphology, and mechanical testing; study elastomers, plastics, and fibers; learn from practical examples from fields of adhesion and composites; and understand the measurement of properties of polymers, which are then discussed as functions of chemical composition, molecular weight, topology, morphology, etc.
Gas Chromatography: Fundamentals, Troubleshooting, and Method Development by Daniel Fishman — last modified 06-30-09 07:19 AM: This course is designed for beginners and intermediate-level practitioners who want practical laboratory experience in gas chromatography (GC). The lectures—supplemented by problem sets, slides, and video presentations—provide the fundamentals needed to understand the technique and instrumentation involved in this powerful analytical tool. At the end of the class, you will have mastered the fundamentals of GC, participated in five hands-on laboratory sessions, performed reference and literature searches, and learned specialized techniques based on your specific interests.
3rd International Symposium on Metallomics by Michael Michael Sperling — last modified 06-30-09 07:15 AM: The 3rd International Symposium on Metallomics will feature a host of sessions, stimulating the interdisciplinary discussion between analytical chemists, biologists, physicians and clinical scientists from industry, government, academia, doctoral and graduate students. The main topics are: * Techniques and methods for metallomics (new instrumentation and technology, metal tags and labels, metal imaging and new methods) * Human Metallomics * BioGeo Metallomics * Phyto Metallomics * Microbial Metallomics * Environmental Metallomics
High Performance Liquid Chromatography: Fundamentals, Troubleshooting, and Method Development by Daniel Fishman — last modified 06-30-09 07:14 AM: This course is designed for beginning- and intermediate-level users in HPLC who want practical laboratory experience. The lectures, supplemented by problems sets, slides, and video presentations, provide the fundamentals needed to understand the techniques and instrumentation involved in this powerful analytical tool. Key topics include: basic instrumentation for HPLC; detectors, including UV/VIS, photo diode array, mass spectrometer, and fluorescence; column selection and optimization, qualitative and quantitative analysis; and troubleshooting HPLC systems.
Gas Chromatography: Fundamentals, Troubleshooting, and Method Development by Daniel Fishman — last modified 06-30-09 07:13 AM: This course is designed for beginners and intermediate-level practitioners who want practical laboratory experience in gas chromatography (GC). The lectures—supplemented by problem sets, slides, and video presentations—provide the fundamentals needed to understand the technique and instrumentation involved in this powerful analytical tool. At the end of the class, you will have mastered the fundamentals of GC, participated in five hands-on laboratory sessions, performed reference and literature searches, and learned specialized techniques based on your specific interests.
High Performance Liquid Chromatography: Fundamentals, Troubleshooting, and Method Development by Daniel Fishman — last modified 06-30-09 07:13 AM: This course is designed for beginning- and intermediate-level users in HPLC who want practical laboratory experience. The lectures, supplemented by problems sets, slides, and video presentations, provide the fundamentals needed to understand the techniques and instrumentation involved in this powerful analytical tool. Key topics include: basic instrumentation for HPLC; detectors, including UV/VIS, photo diode array, mass spectrometer, and fluorescence; column selection and optimization, qualitative and quantitative analysis; and troubleshooting HPLC systems.
Meet the UCB BioExec Institute 2009 Faculty Leader by Daniel Fishman — last modified 06-02-09 03:02 AM: Meet the Faculty Leaders for the BioExec Institute 2009, the only BioPharma executive education series specifically designed to discuss business strategies with key leaders who have provided unique value to the industry.
Making Yourself a Target by Daniel Fishman — last modified 06-02-09 02:51 AM: Mergers and Acquisitions are on the rise, and businesses throughout the industry are preparing their next steps. Big BioTech companies have the power to purchasing 2009 intellect for 1999 prices. Find out what it takes to make your business attractive to larger companies, while maintaining worth. Discover who’s looking, and how to become a M&A target. Join this panel to hear M&A strategy perspectives from the purchased, the purchaser, the investor, and the lawyer. This panel will give you the opportunity to meet with M&A pros, and help you plan your next move.
Qualification and Validation of Laboratory Instruments and Equipment for Regulatory and QS Compliance (IQ, OQ, PQ) by Daniel Fishman — last modified 06-02-09 02:47 AM: Understand the process for design, installation, operation and performance (DQ, IQ, OQ, PQ) in the analytical laboratory. Learn what regulatory and quality systems requirements are for compliance and conformity, how to implement qualification and validation systems and keep them current to meet business needs, how to perform necessary maintenance through PM, and how to adapt your current GLP system to meet changing requirements.
California Green Chemistry Initiative by Daniel Fishman — last modified 06-02-09 02:40 AM: In furtherance of California's Green Chemistry Initiative, the legislature enacted two statutes late last year which authorized California state government to develop an alternatives analysis framework to stimulate the rapid acceleration of replacement of harmful chemicals and ingredients with safer alternatives in consumer products sold in California. The statutory definition of "consumer product" is very broad: "a product or part of the product that is used, brought, or leased for use by a person for any purposes." The only products explicitly excluded from the definition are drugs and medical devices, dental restorative materials, food, packaging for drugs, devices, dental restorative materials and food, pesticides, and mercury containing lights. California's Department of Toxic Substances Control ("DTSC") is currently drafting the implementing regulations. The regulations will establish a process to identify and prioritize chemicals of concern (CoCs); establish a process to assess safer alternatives; and establish a range of regulatory responses that DTSC may take following the safer alternatives analysis. DTSC intends to have the regulations ready for public comment by September 2009, with the goal of having the regulations in place by the end of the year. The regulations will undoubtedly have a significant impact on most industries. Apart from the burden on resources imposed by undertaking alternatives assessments, the regulations may necessitate changes in R&D strategies, supply-chain relationships, and the way in which companies manage their intellectual property.
BIO-Europe 2009 by Daniel Fishman — last modified 06-02-09 02:35 AM: BIO-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry.
17th Annual Gene Acres Conference by Daniel Fishman — last modified 06-02-09 02:30 AM: Gene Acres is a one-day facilities conference featuring timely analysis of issues by professionals from multiple perspectives. From facilities design to security, and from regulatory certification to international operations, Gene Acres conference provides insights into the challenges faced by life science companies every day. A closing reception will provide a perfect opportunity to network with your peers.
BioPharm America™ 2009 by Daniel Fishman — last modified 06-02-09 02:24 AM: BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE™, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe and BIO-Europe Spring®.
Qualification and Validation of Laboratory Instruments and Equipment for Regulatory and QS Compliance (IQ, OQ, PQ) by Daniel Fishman — last modified 05-29-09 03:02 AM: Understand the process for design, installation, operation and performance (DQ, IQ, OQ, PQ) in the analytical laboratory. Learn what regulatory and quality systems requirements are for compliance and conformity, how to implement qualification and validation systems and keep them current to meet business needs, how to perform necessary maintenance through PM, and how to adapt your current GLP system to meet changing requirements.
Statistical Analysis of Laboratory Data by Daniel Fishman — last modified 05-29-09 02:58 AM: Master the fundamentals of laboratory data treatment to solve data analysis problems. Through a combination of lectures and problem-solving sessions, this course will teach statistical techniques that can be put to immediate use in the workplace. Participants will learn how to understand the strengths and weaknesses of data, recognize and reduce different types of errors, carry out significance tests, correctly use outlier tests, and more.
Polyolefins 101 by Daniel Fishman — last modified 05-29-09 02:55 AM: This course is an intensive review of fundamentals of polyolefins, polymers that are used in innumerable products essential to modern life. Practical aspects are emphasized, answering questions such as: What are polyolefins and how do they differ? How are they manufactured and processed into the myriad products we encounter everyday? and What are the markets for polyolefins?
Introduction and Use of Standard Methods for Environmental Regulatory Analysis and Compliance by Daniel Fishman — last modified 05-29-09 02:52 AM: This course will focus on how to use "Standard Methods for the Examination of Water and Wastewater" to meet CWA-SDWA regulations. Topics will include the chemical reactions utilized for analyte detection, the development of SOPs utilizing sections of Standard Methods, troubleshooting analyte analysis methods, and preparing for a State, Federal, or NELAC-TNI audit. This class will utilize examples from the environmental industry and the current edition of Standard Methods.
Effective Supervision of Scientists and the Technical Staff by Daniel Fishman — last modified 05-29-09 02:48 AM: This course will help technical managers improve their skills by teaching effective management techniques, how to motivate staff for more creative output and participation, how to improve problem-solving abilities, and how to create a positive work atmosphere. For supervisors of scientists, engineers, and other technical staff members who want to strengthen their leadership skills.
Methods Development, Validation Procedures, and Conformity Assessment in the Analytical Laboratory by Daniel Fishman — last modified 05-29-09 02:26 AM: Learn the fundamentals of quality assurance, quality control, and analytical methods validation and how to improve your FDA, WHO and OECD regulatory compliance directives for analytical data submissions. Key topics covered include: conformity assessment; analytical method optimization during development; case studies in the improvement of validation characteristics; data integrity and statistical evaluation of analytical data; and more.
Methods Development, Validation Procedures, and Conformity Assessment in the Analytical Laboratory by Daniel Fishman — last modified 05-29-09 02:23 AM: Learn the fundamentals of quality assurance, quality control, and analytical methods validation and how to improve your FDA, WHO and OECD regulatory compliance directives for analytical data submissions. Key topics covered include: conformity assessment; analytical method optimization during development; case studies in the improvement of validation characteristics; data integrity and statistical evaluation of analytical data; and more.
Laboratory Safety by Daniel Fishman — last modified 05-29-09 02:19 AM: Learn best practices to minimize personal injury, health impairment, property loss, fines, and liability in your laboratory. This course gives you an overview of the practical and latest regulatory measures for the prevention of accidents, incidents, or exposures that may cause health impairment, injury, fire, or interference with laboratory operations. It includes the OSHA training requirements for a Chemical Hygiene Officer.
Laboratory Safety by Daniel Fishman — last modified 05-29-09 02:15 AM: Learn best practices to minimize personal injury, health impairment, property loss, fines, and liability in your laboratory. This course gives you an overview of the practical and latest regulatory measures for the prevention of accidents, incidents, or exposures that may cause health impairment, injury, fire, or interference with laboratory operations. It includes the OSHA training requirements for a Chemical Hygiene Officer.
Introduction and Use of Standard Methods for Environmental Regulatory Analysis and Compliance by Daniel Fishman — last modified 05-26-09 06:10 AM: In this course, you will learn how to meet CWA-SDWA regulations by using “Standard Methods for the Examination of Water and Wastewater.” Using examples from the environmental industry, we will focus on the chemical reactions utilized for analyte detection, development of SOPs utilizing Standard Methods, troubleshooting analyte analysis methods, and prepping for an audit.
Polymorphism in Organic/Pharmaceutical Systems by Daniel Fishman — last modified 05-26-09 06:07 AM: In this course, you will learn how to meet CWA-SDWA regulations by using “Standard Methods for the Examination of Water and Wastewater.” Using examples from the environmental industry, we will focus on the chemical reactions utilized for analyte detection, development of SOPs utilizing Standard Methods, troubleshooting analyte analysis methods, and prepping for an audit.
Polymorphism in Organic/Pharmaceutical Systems by Daniel Fishman — last modified 05-26-09 05:53 AM: In this course, we will review the fundamentals of polymorphism, including the basics of polymorph characterization, screening, and crystallization. Polymorph changes during processing (API and drug product), the effect these changes have on development timelines, and how to minimize these changes will also be discussed. We will also cover choosing the best form for product development and how it relates to regulatory filings, patent applications, and lifecycle management.
Polymorphism in Organic/Pharmaceutical Systems by Daniel Fishman — last modified 05-26-09 05:50 AM: In this course, we will review the fundamentals of polymorphism, including the basics of polymorph characterization, screening, and crystallization. Polymorph changes during processing (API and drug product), the effect these changes have on development timelines, and how to minimize these changes will also be discussed. We will also cover choosing the best form for product development and how it relates to regulatory filings, patent applications, and lifecycle management.
Fourier Transform Infrared Spectroscopy by Daniel Fishman — last modified 05-26-09 05:46 AM: Learn how to use FTIR to solve on-the-job problems quickly and efficiently. Anyone who performs chemical analysis needs to know about FTIR. Regardless of which industry you work in, if you need to identify the molecules in a sample, you will benefit from this course. If you already use FTIR, you will see how to perform your analyses faster and cheaper and learn to optimize spectral quality while minimizing analysis time.
Fourier Transform Infrared Spectroscopy by Daniel Fishman — last modified 05-26-09 05:43 AM: Learn how to use FTIR to solve on-the-job problems quickly and efficiently. Anyone who performs chemical analysis needs to know about FTIR. Regardless of which industry you work in, if you need to identify the molecules in a sample, you will benefit from this course. If you already use FTIR, you will see how to perform your analyses faster and cheaper and learn to optimize spectral quality while minimizing analysis time.
Patent Law Fundamentals Webcast Course by Daniel Fishman — last modified 05-26-09 05:39 AM: This seminar is intended as an introductory primer in US patent law for scientists, engineers, and managers involved in business and technology. The seminar covers the fundamentals of how to: * Identify and document an invention * Search for patents related to the invention * Apply for a patent application Attendees will become familiar with the types of patent applications, patentability requirements, the parts of a patent application, and the prosecution process for getting a patent application allowed before the United States Patent and Trademark Office (USPTO).
Introduction to Process Analytical Chemistry by Daniel Fishman — last modified 05-26-09 05:29 AM: Learn how to conduct a process analytical project and what are the principal process analytical chemistry (PAC) technologies to consider. This course will meet for 5 online sessions of 2 and one half hours each. October 6, 13, 20, 27, and November 3
Introduction to Process Analytical Chemistry by Daniel Fishman — last modified 05-26-09 05:26 AM: Learn how to conduct a process analytical project and what are the principal process analytical chemistry (PAC) technologies to consider. This course will meet for 5 online sessions of 2 and one half hours each. June 2, 9, 16, 23 30
Pharmacokinetics and Pharmacodynamics for Chemists by Daniel Fishman — last modified 05-26-09 05:33 AM: This course will meet for six online sessions of one hour and 15 minutes each. September 24; October 1, 8, 15, 22, 29. This course presents the fundamentals of Pharmacokinetics and Pharmacodynamics as they apply to the chemical structure of drugs. There will be specific discussion of the role of medicinal chemistry in the drug discovery process; how chemical structure affects the absorption, distribution, metabolism and excretion (ADME properties) of drugs; and drug affinity and efficacy (Pharmacodynamics). In addition, students will learn the essentials of interpreting pharmacokinetic data from animal studies for prediction of first dose in humans and therapeutic use of drugs. By the end of this course, students should be able to understand the role of the medicinal chemist in the process of drug discovery and development. This course is centered on gaining an understanding of in vitro PK assay data (Caco-2, MDCK, PAMPA, microsomes, hepatocytes etc) to predict in vivo PK and optimize drug ADME properties. In vivo data interpretation (scaling from animal to humans, allometric plots) will be discussed with specific examples of the role of pharmacokinetics in drug development.
Pharmacokinetics and Pharmacodynamics for Chemists by Daniel Fishman — last modified 05-26-09 04:56 AM: This course presents the fundamentals of Pharmacokinetics and Pharmacodynamics as they apply to the chemical structure of drugs. There will be specific discussion of the role of medicinal chemistry in the drug discovery process; how chemical structure affects the absorption, distribution, metabolism and excretion (ADME properties) of drugs; and drug affinity and efficacy (Pharmacodynamics). In addition, students will learn the essentials of interpreting pharmacokinetic data from animal studies for prediction of first dose in humans and therapeutic use of drugs. By the end of this course, students should be able to understand the role of the medicinal chemist in the process of drug discovery and development. This course is centered on gaining an understanding of in vitro PK assay data (Caco-2, MDCK, PAMPA, microsomes, hepatocytes etc) to predict in vivo PK and optimize drug ADME properties. In vivo data interpretation (scaling from animal to humans, allometric plots) will be discussed with specific examples of the role of pharmacokinetics in drug development.
Pharmacokinetics and Pharmacodynamics for Chemists by Daniel Fishman — last modified 05-26-09 04:56 AM: This course presents the fundamentals of Pharmacokinetics and Pharmacodynamics as they apply to the chemical structure of drugs. There will be specific discussion of the role of medicinal chemistry in the drug discovery process; how chemical structure affects the absorption, distribution, metabolism and excretion (ADME properties) of drugs; and drug affinity and efficacy (Pharmacodynamics). In addition, students will learn the essentials of interpreting pharmacokinetic data from animal studies for prediction of first dose in humans and therapeutic use of drugs. By the end of this course, students should be able to understand the role of the medicinal chemist in the process of drug discovery and development. This course is centered on gaining an understanding of in vitro PK assay data (Caco-2, MDCK, PAMPA, microsomes, hepatocytes etc) to predict in vivo PK and optimize drug ADME properties. In vivo data interpretation (scaling from animal to humans, allometric plots) will be discussed with specific examples of the role of pharmacokinetics in drug development.
Experimental Design for Productivity and Quality in Research & Development by Daniel Fishman — last modified 05-26-09 04:33 AM: Learn how to significantly improve your R&D quality and efficiency and how to match appropriate experimental designs to real-world problems with two expert instructors. Basic concepts of experimental design will be covered, as well as strengths and limitations of popular experimental design techniques; the applicability of common designs; and determining which experimental designs are appropriate or inappropriate for particular situations. The course assumes no previous knowledge of statistics and is aimed at both beginning and experienced R&D scientists.
Tandem Mass Spectrometry of Biological Molecules by Daniel Fishman — last modified 05-26-09 04:29 AM: Most mass spectra recorded from biological molecules are based on fragmentations of even-electron ions. However, there are no books dedicated to interpretation of even-electron-ion spectra. Traditional, well-established fragmentations mechanisms are pertinent only to odd-electron ions derived by electron ionization procedures. This new course is designed to fill this void.
Introduction to Modern Mass Spectrometry by Daniel Fishman — last modified 05-26-09 04:25 AM: This course covers mass spectrometry fundamentals as well as the latest developments in the field, with emphasis on biological and biochemical applications. You will: learn strategic procedures followed by mass spectrometrists; improve the way you approach solving an analytical problem by mass spectrometry; learn about interfacing chromatographic procedures with mass spectrometry; and learn peripheral technologies required for mass spectrometry.
Infrared Spectra Interpretation: A Systematic Approach by Daniel Fishman — last modified 05-26-09 04:22 AM: Improve your ability to identify molecules using infrared spectrometry. This course is appropriate for technicians who seek to improve their skills and advance their careers, and for managers whose labs have an FTIR and who need to understand what information the device yields so they can manage their labs more intelligently.
Fourier Transform Infrared Spectroscopy: A Hands-on Workshop by Daniel Fishman — last modified 05-26-09 04:19 AM: Learn how to use FTIR to solve on-the-job problems quickly and efficiently. Anyone who performs chemical analysis needs to know about FTIR. Regardless of which industry you work in, if you need to identify the molecules in a sample, you will benefit from this course. If you already use FTIR, you will see how to perform your analyses faster and cheaper and learn to optimize spectral quality while minimizing analysis time.
Polymeric Coatings by Daniel Fishman — last modified 05-26-09 04:15 AM: This course covers contemporary coatings science topics. You will learn about technology that helps you understand and solve coatings needs while also meeting existing environmental regulations. You will also find out how to select appropriate coatings components for your use, overcome the limitations of contemporary coatings technology, and understand the role of resins and polymers, pigments, solvents, and additives in a coatings formulation. Interactions between coatings components and the function that each plays in the manufacture and performance of polymeric coatings will also be covered.
Polymer Chemistry by Daniel Fishman — last modified 05-26-09 04:12 AM: This course gives an overview of the polymer field from the synthesis of polymers to characterization, properties, and applications of polymers. All major synthetic methods are considered: step (condensation) polymerization, chain (addition) polymerization with ionic and radical variations, copolymerization, stereospecific polymerization, ring-opening polymerization, and synthetic reactions on formed polymers. Emphasis is placed on how the various synthetic methods are used to control structural features such as molecular weight, branching, crosslinking, and crystallinity. Among the properties that are analyzed are polymer solubility, molecular weight and molecular weight distribution, crystallinity (versus amorphous behavior), transition temperatures, mechanical properties, and the processing of polymers into useful products. The effect of molecular structure on these properties and the utilization of polymers are discussed in detail.
Project Management for Technical Professionals by Daniel Fishman — last modified 05-26-09 04:06 AM: Become more successful in planning and managing cross-functional project teams. Through this course, learn the art and science involved in running successful cross-functional project teams, determining project goals and objectives, the three key measurement criteria and how to apply them, how to conduct go/no-go gate reviews, and ways to document organizational learning.
7th Winter Symposium on Chemometrics (WSC-7) by Alexey Pomerantsev — last modified 05-22-09 04:01 AM: The 7th Winter Symposium on Chemometrics (WSC-7) will be held near Saint Petersburg, Russia in February 15-19, 2010. The conference is organized under the auspices of the Russian Chemometrics Society, Saint Petersburg State Technological University of Plant Polymers, ACABS Research Group of University of Aalborg (Esbjerg), and Lappeenranta University of Technology. The conference brings together both academic scientists and industrial experts providing all conditions for their fruitful communication. Traditionally, WSC is friendly to young scientists and those beginning to carve their way in the data analysis. Participants are invited to deliver not only their final results but also discuss preliminary problem statements and methods, all in a strictly friendly atmosphere The submitted manuscripts of the previous WSC-6 conference have recently been published in a special issue of Chemomerics and Intelligent Laboratory Systems (V 97, Issue 1 ) For more information, please contact the secretary of WSC-7, Olga Derkacheva at wsc7@chemometrics.ru
Recent Developments in Organic Synthesis by Daniel Fishman — last modified 05-21-09 06:39 AM: This course on pharmaceutical process research will focus on the design and development of practical syntheses for product candidates. The importance of combining synthetic organic chemistry with physical/mechanistic organic chemistry and innovation is stressed. It is designed to expose participants to all phases of drug process development, from preclinical to New Drug Application filing. Numerous examples will be used to illustrate key aspects of process research, including issues related to US Good Manufacturing and Good Laboratory Practices (cGMP/GLP), as well as those related to the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Real life examples will address creativity, timeline, economic, environmental, analytical, formulation, final form, cGMP, impurity, and regulatory issues.
Process Research in the Pharmaceutical Industry: The Design and Development of Practical Syntheses by Daniel Fishman — last modified 05-21-09 06:36 AM: This course on pharmaceutical process research will focus on the design and development of practical syntheses for product candidates. The importance of combining synthetic organic chemistry with physical/mechanistic organic chemistry and innovation is stressed. It is designed to expose participants to all phases of drug process development, from preclinical to New Drug Application filing. Numerous examples will be used to illustrate key aspects of process research, including issues related to US Good Manufacturing and Good Laboratory Practices (cGMP/GLP), as well as those related to the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Real life examples will address creativity, timeline, economic, environmental, analytical, formulation, final form, cGMP, impurity, and regulatory issues.
NMR Spectral Interpretation and Organic Spectroscopy: A Problem-Based Learning Approach by Daniel Fishman — last modified 05-21-09 06:32 AM: Anyone who does organic synthesis and uses spectroscopic data to assign the structures of reaction products will want to attend this course. Topics include: identifying organic functional groups by 13C NMR data; deducing structures from 13C NMR data; understanding 1H NMR spectra; finding connectivity using 1H NMR coupling constants; deducing benzene substitution using 13C and 1H NMR data; and using UV and mass spectrometry.
NMR Spectral Interpretation and Organic Spectroscopy: A Problem-Based Learning Approach by Daniel Fishman — last modified 05-21-09 06:29 AM: Anyone who does organic synthesis and uses spectroscopic data to assign the structures of reaction products will want to attend this course. Topics include: identifying organic functional groups by 13C NMR data; deducing structures from 13C NMR data; understanding 1H NMR spectra; finding connectivity using 1H NMR coupling constants; deducing benzene substitution using 13C and 1H NMR data; and using UV and mass spectrometry.
Mastering the Art of Writing Reasonable Organic Reaction Mechanisms by Daniel Fishman — last modified 05-21-09 06:26 AM: This course is aimed at B.S. and M.S. chemists in the pharmaceutical and contract syntheses industries looking to improve upon their ability to draw a reasonable mechanism for any complex organic transformation. Registrants will need to purchase a copy of The Art of Writing Reasonable Organic Reaction Mechanisms, 2nd edition, in addition to their registration before the course starts. You should read sections 1.1 to 1.3 and work the corresponding problems at the end of Chapter 1 before arriving to the course. Bring the text to the course.
Dispersion in Liquids: Suspensions, Emulsions, and Foams by Daniel Fishman — last modified 05-21-09 06:12 AM: Help solve your colloidal, foam, and dispersion problems in this course designed for scientists and engineers engaged in research and development in the chemical, petroleum, coatings, food, electronics, pharmaceutical, cosmetics, and ceramics industries. Topics covered will include surface and interfaces, surfactants, nanoparticle technology, interparticle forces and stability, laboratory techniques, emulsion technology, dispersion processing, foam technology, and polymer stabilization.
Project Management for Technical Professionals by Daniel Fishman — last modified 05-21-09 06:08 AM: Become more successful in planning and managing cross-functional project teams. Through this course, learn the art and science involved in running successful cross-functional project teams, determining project goals and objectives, the three key measurement criteria and how to apply them, how to conduct go/no-go gate reviews, and ways to document organizational learning.
Mastering the Art of Writing Reasonable Organic Reaction Mechanisms by Daniel Fishman — last modified 05-21-09 06:02 AM: This course is aimed at B.S. and M.S. chemists in the pharmaceutical and contract syntheses industries looking to improve upon their ability to draw a reasonable mechanism for any complex organic transformation. Registrants will need to purchase a copy of The Art of Writing Reasonable Organic Reaction Mechanisms, 2nd edition, in addition to their registration before the course starts. You should read sections 1.1 to 1.3 and work the corresponding problems at the end of Chapter 1 before arriving to the course. Bring the text to the course.
Effective Technical Writing (English as a Second Language version) by Daniel Fishman — last modified 05-21-09 05:58 AM: Improve your professional writing skills in this interactive workshop. This class is specifically designed for researchers, technical professionals, and managers who want to enhance their professional success by writing effectively and persuasively. Class size is limited to 20 participants to ensure individual attention. You are encouraged to bring samples of your own writing along with technical writing samples (such as scientific papers, reports, reviews, etc.) that you aspire to write. In addition, the instructor will confer with students about the writing assignments they complete during the course. Each student will be able to print a comprehensive course workbook.
Practical Approaches to Patents and Other Forms of Intellectual Property by Daniel Fishman — last modified 05-21-09 05:55 AM: Learn the fundamentals of writing patent applications and developing patent filing strategies.
Chemical Engineering and Process Fundamentals for Chemists by Daniel Fishman — last modified 05-21-09 05:49 AM: This course will help chemists and other scientists bridge the gap between the research lab and the plant. It offers practical, timely information on chemical reactor design, reaction systems, and chemical process economics; the interaction of chemical engineering and chemical phenomena and processes; non isothermal batch reactors, combined absorption, and chemical reactions; and fluid flow, heat transfer, mass transfer, pumps, heat exchangers, and separation processes.
Essentials of Computer-Assisted Drug Design by Daniel Fishman — last modified 05-21-09 05:46 AM: This introductory course will be especially valuable to both industrial and academic chemists and other R&D scientists who wish to use computer-based methods to enhance the productivity of their research in the fields of organic chemistry, medicinal chemistry, biochemistry, or molecular design for pharmaceutical or agrochemical applications. The relevant medicinal chemistry background and concepts will be presented. While covering the fundamental concepts behind the methods, this course will provide a strong focus on the practical aspects of computational chemistry and computer-assisted drug design. The course instructors will present an overview of approaches for both ligand and target discovery such as similarity searching, pharmacophore modeling, QSAR, structure-based drug design (docking and scoring), virtual screening, ADMET property prediction, as well as relevant elements of bioinformatics (DNA and protein sequence and structure analysis).
Practical HPLC in Pharmaceutical Analysis by Daniel Fishman — last modified 05-21-09 05:42 AM: Analytical procedures are used to assure that the drug product meets applicable standards of identity, strength, quality, and purity during its expiration dating. The majority of analytical methods used in pharmaceutical development are HPLC analyses. cGMPs require stability indicating methods to monitor the drug product’s stability profiles. Therefore, method development and validation significantly impact the drug development process. Additional expectations are also placed on the monitoring of impurities and degradation products. This course focuses on reversed-phase analysis of drug substances and drug products (small molecule). It will discuss forced degradation strategies to develop stability-indicating analytical procedures. A review of ICH guidelines on validation and impurities will be done to help Pharmaceutical Manufacturers to gain better understanding of method validation by phases of drug development and regulatory expectations through a review of warning letters.
Introduction to Process Analytical Chemistry by Daniel Fishman — last modified 05-21-09 05:38 AM: Learn how to conduct a process analytical project and what are the principal process analytical chemistry (PAC) technologies to consider.
High-Throughput Drug Analysis by LCMS by Daniel Fishman — last modified 05-21-09 05:33 AM: The introduction of combinatorial chemistry technology has significantly increased the amount of compounds generated in pharmaceutical industry. Conventional analytical approaches simply cannot keep up. These circumstances have caused drug discovery and development to take on the shape of a bottleneck, like traffic through a toll booth. In order to break the bottleneck, a corresponding revolutionary improvement to the conventional methodology must happen. High-throughput drug analysis is a new topic for drug discovery and development. This short course will mainly focus on the most recent significant advances of high-throughput analyses in the pharmaceutical industry.
Fundamentals of High Performance Liquid Chromatography by Daniel Fishman — last modified 05-21-09 05:30 AM: Gain a sound working knowledge of high performance liquid chromatography methods, techniques and equipment. This course will teach how to use and optimize HPLC columns, interpret and troubleshoot from chromatograms and offer an opportunity to discuss analytical laboratory problems with recognized experts.
Structure Based Drug Design by Daniel Fishman — last modified 05-21-09 05:23 AM: Learn how to use computational chemistry in medicinal chemistry, specifically to identify, refine, and design inhibitors. Topics covered include: how computational methods are used in the drug discovery process; why drug-receptor interactions are important to drug efficacy; how to identify and design specific, more effective enzyme inhibitors and receptor antagonists; cheminformatics; in silico screening; and ADME/Tox profiling.
Process Research in the Pharmaceutical Industry: The Design and Development of Practical Syntheses by Daniel Fishman — last modified 05-21-09 05:19 AM: This course on pharmaceutical process research will focus on the design and development of practical syntheses for product candidates. The importance of combining synthetic organic chemistry with physical/mechanistic organic chemistry and innovation is stressed. It is designed to expose participants to all phases of drug process development, from preclinical to New Drug Application filing. Numerous examples will be used to illustrate key aspects of process research, including issues related to US Good Manufacturing and Good Laboratory Practices (cGMP/GLP), as well as those related to the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Real life examples will address creativity, timeline, economic, environmental, analytical, formulation, final form, cGMP, impurity, and regulatory issues.
Practical HPLC in Pharmaceutical Analysis by Daniel Fishman — last modified 05-21-09 05:15 AM: Analytical procedures are used to assure that the drug product meets applicable standards of identity, strength, quality, and purity during its expiration dating. The majority of analytical methods used in pharmaceutical development are HPLC analyses. cGMPs require stability indicating methods to monitor the drug product’s stability profiles. Therefore, method development and validation significantly impact the drug development process. Additional expectations are also placed on the monitoring of impurities and degradation products. This course focuses on reversed-phase analysis of drug substances and drug products (small molecule). It will discuss forced degradation strategies to develop stability-indicating analytical procedures. A review of ICH guidelines on validation and impurities will be done to help Pharmaceutical Manufacturers to gain better understanding of method validation by phases of drug development and regulatory expectations through a review of warning letters.
Introduction to Process Analytical Chemistry by Daniel Fishman — last modified 05-21-09 05:11 AM: Learn how to conduct a process analytical project and what are the principal process analytical chemistry (PAC) technologies to consider.
Introduction to Drug Metabolism: Role and Practice in Drug Discovery and Development by Daniel Fishman — last modified 05-21-09 05:07 AM: Learn about generating, interpreting, and using drug metabolism data to support drug discovery—from lead selection and optimization to drug registration.
High-Throughput Drug Analysis by LCMS by Daniel Fishman — last modified 05-21-09 04:42 AM: The introduction of combinatorial chemistry technology has significantly increased the amount of compounds generated in pharmaceutical industry. Conventional analytical approaches simply cannot keep up. These circumstances have caused drug discovery and development to take on the shape of a bottleneck, like traffic through a toll booth. In order to break the bottleneck, a corresponding revolutionary improvement to the conventional methodology must happen. High-throughput drug analysis is a new topic for drug discovery and development. This short course will mainly focus on the most recent significant advances of high-throughput analyses in the pharmaceutical industry.
Essentials of Medicinal Chemistry and Pharmacology by Daniel Fishman — last modified 05-21-09 04:29 AM: This course is for chemical scientists who have little or no formal training in physiology, pharmacology, or medicinal chemistry. It reviews key concepts and principles of those sciences, including: * Modern concepts of drug action, drug-receptor interactions, and pharmacophore analysis * Molecular basis for the mechanism of action of drugs * Concepts in PK and PD, drug efficacy and potency, physiological effects, and structure/function relationships * Modern drug design approaches, including structure-based and ligand-based drug design * ADME/tox
Essentials of Biochemistry for Drug Hunters by Daniel Fishman — last modified 05-21-09 05:00 AM: A review of fundamental concepts in biochemistry as applied to the process of drug discovery. Topics include: basic principles of assay development, including how to optimize parameters for high throughput screening; how to obtain and calculate important parameters of drug candidates and their limitations; criteria used for drug candidate selection; and the fundamentals of structure-aided drug design, including use of computer modeling.
Drug-Like Properties in Drug Discovery by Daniel Fishman — last modified 05-21-09 04:53 AM: This course is designed to increase your knowledge of drug-like properties, ADME and how to apply this information in medicinal chemistry for hit selection, lead optimization and development candidate selection and is designed for medicinal chemists and other discovery scientists who design, synthesize, and test new drug candidates, lead research teams, or measure and predict ADMET properties of compounds.
Essentials of Computer-Assisted Drug Design by Daniel Fishman — last modified 05-21-09 04:51 AM: This introductory course will be especially valuable to both industrial and academic chemists and other R&D scientists who wish to use computer-based methods to enhance the productivity of their research in the fields of organic chemistry, medicinal chemistry, biochemistry, or molecular design for pharmaceutical or agrochemical applications. The relevant medicinal chemistry background and concepts will be presented. While covering the fundamental concepts behind the methods, this course will provide a strong focus on the practical aspects of computational chemistry and computer-assisted drug design. The course instructors will present an overview of approaches for both ligand and target discovery such as similarity searching, pharmacophore modeling, QSAR, structure-based drug design (docking and scoring), virtual screening, ADMET property prediction, as well as relevant elements of bioinformatics (DNA and protein sequence and structure analysis).
Chemical Toxicology: A Chemist’s Roadmap to Reduce Bioactivation Liabilities in Drug Candidates by Daniel Fishman — last modified 05-21-09 04:49 AM: Increase your overall knowledge of mechanisms of drug metabolism mediated toxicity.
Capillary Electrophoresis of Biomolecules by Daniel Fishman — last modified 05-21-09 04:46 AM: Capillary electrophoresis is increasingly employed to replace labor intensive slab-gel methods. This two (2) day short course is designed for those new to CE although experienced users who wish to broaden their background will especially benefit. The course begins with an extensive review describing that factors that influence the electrophoretic migration of molecules in fluid solution. A phenomological approach is employed that enables the student to take home a thorough understanding of electrophoretic processes. The instructor uses examples ranging from the simple to the complex to explain the movement of ions in fluid solution under the influence of the applied field. Because of this, by the end of this two-day course, you will gain an in-depth understanding of electrophoretic events and methods development and troubleshooting will rapidly become an intuitive process. Key Topics * How to implement capillary electrophoresis to replace and/or complement slab-gel electrophoresis * The mechanisms of capillary electrophoretic separations from a phenomenological viewpoint * How to optimize the background electrolyte for problem separations * Where to locate the best sources of technical information * How to prepare samples that are optimized for capillary electrophoresis * Considerations for method transfer and validation
Analytical Method Transfer of Pharmaceutical Products by Daniel Fishman — last modified 05-21-09 04:44 AM: Analytical methods are a major tool in the pharmaceutical development to control the quality and integrity of the active drug substance or drug product. Methods are normally developed at one site and then transferred to one or more sites during the drug development process. Qualifying analysts to perform these methods is a critical activity that would significantly impact the launch of a product. Activities of a method transfer process must be managed effectively to deliver an analytical method from one site to another or one department to another. This course will present fundamental principles of a method transfer, examine different strategies, discuss key factors that would influence the transfer of analytical methods from one site to another. Key Topics * Planning and developing an effective transfer protocol * Exploring key process steps that are site dependent * Selecting appropriate strategies for method transfer * Providing a framework to improve the success of method transfer * Understanding method capabilities to set acceptance criteria
7th Winter Symposium on Chemometrics (WSC-7) by Daniel Fishman — last modified 05-21-09 02:21 AM: The conference is organized under the auspices of the Russian Chemometrics Society, Saint Petersburg State Technological University of Plant Polymers, ACABS Research Group of University of Aalborg (Esbjerg), and Lappeenranta University of Technology. The conference brings together both academic scientists and industrial experts providing all conditions for their fruitful communication. Traditionally, WSC is friendly to young scientists and those beginning to carve their way in the data analysis. Participants are invited to deliver not only their final results but also discuss preliminary problem statements and methods, all in a strictly friendly atmosphere
Discovery & Selection of Successful Drug Candidates with Special Emphasis on Structure-Based Drug Design by Admin — last modified 04-17-09 10:00 PM: In an effort to add value to an already very successful conference, we have expanded the structure-based drug design session of the 5th annual “Discovery & Selection of Successful Drug Candidates” conference to a full day. Chairs Andrew Combs of Incyte, and Greg Roth of The Burnham Institute for Medical Research, are joined this year by co-chair Scott Kuduk of Merck, as well as Vinod Patel of Amgen and Guy Bemis of Vertex, who developed the structure-based drug design portion of this program. Together, they have gathered another group of highly-regarded pharmaceutical industry scientists, who will lecture and collectively present about 20 case studies over the course of the symposia.
11th Frank Warren Conference of the South African Chemical Institute by Gert Kruger — last modified 04-08-09 07:00 AM: It is our pleasure to invite you to participate in the 11th Frank Warren Conference of the South African Chemical Institute. The 11th conference will mark the 50th anniversary of these gatherings. The Frank Warren conference in 2010 will focus on some of the history of this special gathering as well as look to the future. We have invited a number of highly rated international speakers for the conference, and we hope that you will also join us.
Organic Process Research & Development by Sue Parsons — last modified 03-23-09 02:39 AM: This conference brings together chemists and engineers from all parts of the world to discuss issues related to synthetic route design, development and optimisation and the scale-up of these processes. The invited speakers have been selected to emphasise their company’s approach to these issues with detailed case studies.
CHI’s Pre-Clinical/Clinical Development of Vaccines by Robert Black — last modified 03-13-09 04:16 AM: One of the most important scientific challenges for the future is the development of effective vaccines against chronic infections and the application of therapeutic vaccines for the treatment of noninfectious diseases, such as cancer, allergy, and autoimmune disorders. Recently, there has been an increased understanding of the immunological principles governing the immune response to infectious agents. This knowledge is now being applied to the design of new and better vaccines. This conference will provide a forum to evaluate recent nonclinical (preclinical) and clinical developments and technologies in this research area.
CHI’s Novel Vaccines: Adjuvants & Delivery Systems by Robert Black — last modified 03-13-09 04:15 AM: Protecting the world from health threats requires an adequate supply of safe and efficacious vaccines. Novel Vaccines’ “Design & Development” meeting features today’s exciting breakthroughs and promising initiatives that vaccine leaders are advancing to meet critical public needs. Once again experts from around the world will gather to share information and discuss emerging vaccine technologies. Don’t miss the opportunity to be part of the global discussion in the quest to conquer disease.
CHI’s Production & Manufacturing of Vaccines by Robert Black — last modified 03-13-09 04:09 AM: Production and Manufacturing of Vaccines is the practical side of providing vaccines for the world – part science, part art – will be explored. Humanity’s future is threatened by emerging diseases and potential biological weapons. Preparedness can be assured by designing protocols and building infrastructure to meet these challenges. Join in the information exchange as data, methods and wisdom are shared to help vaccine developers meet global demand and protect public health.
CHI’s Novel Vaccines: Design & Development by Robert Black — last modified 03-13-09 04:09 AM: Protecting the world from health threats requires an adequate supply of safe and efficacious vaccines. Novel Vaccines’ “Design & Development” meeting features today’s exciting breakthroughs and promising initiatives that vaccine leaders are advancing to meet critical public needs. Once again experts from around the world will gather to share information and discuss emerging vaccine technologies. Don’t miss the opportunity to be part of the global discussion in the quest to conquer disease.
CHI’s The Immunotherapeutics & Vaccine Summit by Robert Black — last modified 03-13-09 04:08 AM: Meeting the public need and protecting the world from disease remains the paramount concern for vaccine developers. Vaccine experts from around the world will once again come together to share information and discuss critical vaccine issues at this year’s ImVacS event. Major diseases will be discussed along with important breakthroughs and technologies. Don’t miss the opportunity to be part of the global discussion in the quest to conquer disease.
CHI’s Molecular Diagnostics for Infectious Disease by Robert Black — last modified 03-13-09 03:58 AM: Attend this conference to get an insight into how molecular technologies are advancing the development of clinically useful diagnostic tests for infectious diseases in humans, animals and plants both in developed and developing worlds. Hear from leading edge companies who have successfully launched products in this area, from research lab oratories developing cutting edge science in support of this area, smaller companies launching novel tests, the FDAs guidelines on developing products in this area and feedback from Clinical Directors at reference, specialty, service, or central laboratories who ultimately use these tests.
CHI’s Clinical Adoption of Next Generation Diagnostics by Robert Black — last modified 03-13-09 03:57 AM: Clinical adoption of molecular diagnostic by the medical community is vital to the success of novel tests. The process by which new testing protocols become accepted and get incorporated will be explored. Experts from the medical and regulatory community will be speaking on a diverse range of issues. Find out what factors influence the adoption and acceptance of your diagnostic test, and how to navigate the changing regulatory requirements.
CHI’s Trends in Cancer Diagnostics by Robert Black — last modified 03-13-09 03:57 AM: Tremendous progress is being made in cancer diagnostics, and the proliferation of novel tests is truly historic. Gene expression panels from microarray data and next-generation sequencing are being used for the early detection and prognosis of cancer. Tumor aggressiveness and therapy selection are being determined by these technologies, and the number of companies competing in this space is growing rapidly. Plan to attend to learn key factors in implementation and adoption, and gather intelligence about the types of assays from experts in the field.
CHI’s Enabling Point-of-Care Diagnostics by Robert Black — last modified 03-13-09 03:56 AM: The range of utility of point-of-care testing is broad, and ranges from influenza, HIV, emerging pathogens, cardiology, stroke, even cancer applications. The demand for automated and integrated systems and the number of players in the field is growing exponentially. This meeting will showcase technology development with the clinical perspective on where the tests are needed and how they are being used. Case studies to illustrate the impact on patient management and quality of care will show striking examples of the new paradigm in medicine. This meeting will answer what the dominant technologies will be for POC, and how to influence the commercialization and adoption of tests.
CHI’s Next Generation Dx Summit by Robert Black — last modified 03-13-09 03:55 AM: CHI’s Next Generation Dx Summit, to be held August 10-12, 2009 at the Ritz-Carlton Hotel in Washington, DC, will be comprised of four different tracks. Conference tracks include: Enabling Point-of-Care Diagnostics, Trends in Cancer Diagnostics, Clinical Adoption of Next Generation Diagnostics, and Molecular Diagnostics for Infectious Disease.
EuroBiO 2009 by Claire WALLAERT — last modified 02-18-09 06:41 AM: During three days, EuroBiO’s ambition is to be a cutting-edge platform gathering industry and academia thus enhancing exchange and partnership thanks to licensing, collaborative projects and tech transfer. Moreover, EuroBiO offers mature companies the possibility to set up a real dialogue with emerging companies and starts-up which carry relevant innovation for the future of the sector. Thus, 2009’s edition will focus on fundamentals and will bring pragmatic tools meeting the needs of Biosciences and Bioindustries: >> Share know-how and expertise: EuroBiO Conferences, 70 international keynote speakers will share their experience on 3 relevant tracks for today’s and tomorrow’s Biotechs: - Tech Transfer & Collaborative Projects - Emerging Biocompanies issues - Regulatory issues >> Exchanges, Partnerships & Business: EuroBiOpartnering, a platform specifically dedicated & adapted to the matchmaking of the Biosciences community. - Partnering First : companies to companies networking - Investors Hub : Venture Capitals to companies networking - BioTransfer : Academia to Industry matchmaking >> Candidates, recruiters and carriers of projects: EuroBiO Career Fair, the networking of highly-qualified human skills. >> All tools are supported by the EuroBiO Trade Show: a relevant window of European life sciences community.
Euroanalysis 2009 by Wolfgang Buchberger — last modified 02-18-09 06:40 AM: Euroanalysis 2009 is the fifteenth event in a series of premier meetings for discussion and presentation of Analytical Chemistry covering a broad spectrum of advances in analytical technologies as well as their applications in diverse and challenging fields. Euroanalysis 2009 will take place in the convention center Congress Innsbruck situated next to the entrance of the famous Old Town of Innsbruck / Austria The program will consist of invited plenary lectures, oral contributions in parallel sessions, poster sessions, Short Courses, and an exhibition on instrumentation, analytical services and scientific literature.
ACS Spring National Meeting Short Courses by chemweb — last modified 02-12-09 03:04 AM: Check out the 1, 2 and 3 day short courses at the ACS National Meeting in Salt Lake City, UT, March 21-26, 2009. You will also receive a free pass to the Expo with your short course registration. You do not need to register for the national meeting to attend a short course. Early Registration Ends 2/23 for Short Courses! Click link below to register now. "Buy 4, Get One Free" and Early Registration discounts are available. See our website for complete details and to register. Housing is also available.
11th Eurasia Conference on Chemical Sciences by Amal Al-Aboudi — last modified 02-02-09 05:59 AM: The 11th Eurasia Conference on Chemical Sciences (EuAsC2S-11) is to be held in Jordan from October 6 – 10, 2010. The conference is a major international conference, which will present cutting edge advances in various disciplines of chemistry. It will host Nobel laureates and leading scientists. Over 200 eminent scientists from all over the world are expected to participate in this conference. The aim of EuAsC2S is to support young chemists and chemical research in the developing countries by organizing a world- top class international conference. We look for your participation which will promote the success of the conference, inspire young and talented chemists, and open doors for collaboration between chemists from the globe.
21st International Symposium on Pharmaceutical and Biomedical Analysis by Daniel Fishman — last modified 01-21-09 05:24 AM: The 2009 Pharmaceutical and Biomedical Analysis Meeting is a comprehensive forum covering all aspects of pharmaceutical and biomedical analysis. The meeting will have plenary speakers, symposium sessions, poster sessions and a poster podium session. The meeting is a continuation of the successful series that rotates between sites in Europe, Asia and the United States.
New Frontiers in Macromolecular Science by Josef Juza — last modified 01-21-09 03:02 AM: In the year 2009, the Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, will celebrate 50th anniversary of its foundation. This is the very occasion to contemplate current trends in macromolecular science from the view of challenges of science and technology for the 21st century. The meeting shall bring together a diverse group of researchers to discuss general physical, chemical and biological issues of macromolecular systems and let them to evaluate the current role and future prospects of macromolecular science. Starting from macromolecular concepts that can contribute to understanding of processes occurring in living matter, following with principles, on which new bio-inspired materials might be designed, to analysis of physical processes governing molecular and supramolecular organization in macromolecular systems and to new concepts for development of polymers for technology advancement. The meeting will focus on the state of the art theoretical and methodological developments in macromolecular science, however, it will be opened to new hypotheses, emerging ideas and new approaches to experimental methods and design as well. It will provide a unique opportunity for meeting researchers and colleagues in interdisciplinary fields of macromolecular science, and enjoy the exchange of ideas in the inspiring environment of Prague.
Symyx Global Symposium 2009 by Robert Black — last modified 01-21-09 02:57 AM: At Symyx Global Symposium 2009 you will hear case study presentations from industry leaders, receive hands-on training on products and features, interact with users at the scientific poster session, network with peers and technology leaders at topic-focused roundtable discussions, view products and services from Symyx partners that enhance research and development processes, and much more!
CHI’S GENOMIC TOOLS & TECHNOLOGIES by Robert Black — last modified 01-21-09 02:55 AM
CHI’S RNA INTERFACE SUMMIT by Robert Black — last modified 01-21-09 02:55 AM: CHI’s Seventh Annual RNA Interference Summit: From Tools to Therapies meeting, to be held June 8-10, 2009 at the Fairmont Hotel in San Francisco, CA, will be comprised of four different conference tracks, each dedicated to covering a specific aspect of RNAi. Each conference track will be a day and a half event and will feature presentations, posters, and interactive discussions tracking the progress being made in that field and evaluating its impact in the future.
CHI’S BIOMARKER WORLD CONGRESS by Robert Black — last modified 01-21-09 02:55 AM: The signature event in Cambridge Healthtech Institute’s Biomarker Series, The Biomarker World Congress 2009 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. The Congress also offers a balance of scientific sessions covering the latest research and strategic presentations and brainstorming sessions for the decision makers. Now in its fifth h year, the Biomarker World Congress is the leading annual meeting dedicated to biomarker research and implementation that consistently delivers a cutting-edge agenda, 500+ senior delegates, and a sold-out exhibit hall.
CHI’S WORLD PHARMACEUTICAL CONGRESS by Robert Black — last modified 01-21-09 02:55 AM: • Drug Discovery & Innovation Summit • Targeting Pain with Novel Therapeutics • Targeting Alzheimer’s with Novel Therapeutics • Cell and Tissue-Based Assays for HTS • Pharmaceutical Strategy Series • Creating an Effective Alliance Management/Project Management Interface • Drug Safety Summit Sponsored by the Drug Safety Executive Council • Cardiotoxicity and Drug Safety
CHI’S STRUCTURE-BASED DRUG DESIGN by Robert Black — last modified 01-21-09 02:55 AM: Structure-Based Drug Design (SBDD) has been in use within the pharmaceutical industry for over twenty five years. SBDD continues to play an important role in drug discovery, design and optimization. Moreover, with the development of sophisticated biophysical and computational methodologies SBDD is impacting hit identification and ‘hit to lead’ optimization approaches across the industry. In this program, we wish to highlight some recent breakthrough stories and successes using SBDD driven by medicinal chemistry, computational and biophysical approaches.
CHI’S PROTEIN KINASE TARGETS by Robert Black — last modified 01-21-09 02:55 AM: Developing kinase inhibitors has become very attractive for the pharmaceutical industry. Numerous drugs are in phase 3 and beyond, and due to the complexity of the kinome, there are still many opportunities for developing novel inhibitors. In order to stay ahead of the competition in the field it is necessary to keep updated on the current state of the art on lead compounds, as well as on the newest developments in structure-based drug design and the current assay technologies. In addition, discussions on target validation, on how to bring sense into the chemical space and on how to analyze the flood of data available will be presented.
CHI’S COMBINATION PRODUCTS by Robert Black — last modified 01-21-09 02:55 AM: Combination products provide an exciting frontier in therapeutic innovation representing new avenues for the research and development of enhanced drug-drug, drug-biologic, drug-device products, as well as generating novel business opportunities for companies to leverage their existing products and intellectual property. This executive forum will focus on the practical interplay between combination product forefront research, development challenges, and commercial and partnering strategies, as well as the implications for successful market realization. Our speakers are encouraged to share practical real-world experiences and insight. This two-day executive forum entitled “Combination Products: Improving Product Life Cycles, Extending Lines, and Creating Novel Therapeutics” will tackle many of the pressing issues that researchers and executives are facing today.
CHI’S PATIENT RECRUITMENT IN CLINICAL TRIALS by Robert Black — last modified 01-21-09 02:55 AM: Patient recruitment and retention are critical to drug development programs. Patient recruitment, if not adequately planned for, can extend your development timeline by a number of years. Retention of patients throughout the life of a clinical trial is essential in order have complete data sets for your analysis and subsequent filings. In order to optimize both, you have to have a plan. This conference is intended to cover the topics one should consider when drafting a patient recruitment and retention plan for a clinical development program.
BIO-IT WORLD CONFERENCE & EXPO 2009 by Robert Black — last modified 01-21-09 02:55 AM: Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. The 2009 program will feature best practice case studies and joint partner presentations relevant to the technologies, research, and regulatory issues of life science, pharmaceutical, clinical and IT professionals.
CHI’S TOOLS AND METRICS CONGRESS by Robert Black — last modified 01-21-09 02:55 AM: We will be running the Tools and Metrics Congress back-to-back with the 6th Annual Alliance Management Congress, which takes place April 22-23, 2009. This meeting will offer case studies that delve into advanced and fundamental issues of alliance management strategies. The 6th Annual Alliance Management Congress continues to be one of the largest, most prestigious annual conferences in North America for Vice Presidents, Department Heads, Directors, and Managers of Alliance Management and Business Development from biotech and pharmaceutical organizations. Both meetings will come together for a plenary session on the afternoon of April 23 creating a three-day event (April 22-24) covering the topics most important to you.
CHI’S ALLIANCE MANAGEMENT CONGRESS by Robert Black — last modified 01-21-09 02:55 AM: This Alliance Management Congress continues to be one of the largest, most prestigious annual conferences in North America for Vice Presidents, Department Heads, Directors, and Managers of Alliance Management and Business Development from biotech and pharmaceutical organizations. Our 2009 Congress will include novel case studies, strategies, and techniques from thought leaders who have real-world perspectives to share. Per your feedback and suggestions, the Congress will now be designed as a two track program. The first track will offer topics on “advanced skills” for those working in alliance management for more than 5 years. The second track will offer topics on “fundamental skills” for those working in alliance management less than 5 years. There will be shared keynotes and roundtables.
Tenth Tetrahedron Symposium by Sophie Okeke — last modified 01-21-09 02:47 AM: Join us in Paris in June 2009 to celebrate the Tenth Tetrahedron Symposium and the 50th Anniversary of Tetrahedron Letters. Seventeen exceptional speakers, including three Nobel Laureates, will present their latest research findings during this key organic/bioorganic chemistry event for 2009. Attendance at this meeting will enable to you to: Learn from internationally renowned researchers in a comprehensive and wide-ranging programme covering all aspects of organic synthesis; bioorganic, medicinal and computational chemistry; molecular recognition and the organic chemistry of materials. Understand the current state of research and the challenges to future discovery. Present your latest research in the poster sessions. Network with the editors of the Tetrahedron journals, meet with international colleagues, visit the trade stands and make new alliances.
Chemical Control With Electrons and Photons by Ivanka Angelova — last modified 10-08-08 05:28 AM: Grants are available for young researchers to cover the conference fee and travel costs. Topics: ·Chemical Control using ultrashort light pulses ·Chemical Control using low-energy electrons ·Chemical Control at the nanoscale with STM ·Plasma processing and nanofabrication ·Chemical control of biomolecules
CHI’S MICRORNA IN HUMAN DISEASE AND DEVELOPMENT by Robert Black — last modified 10-08-08 05:13 AM: Although microRNAs were brought into the spotlight only recently, their role in regulating mammalian development and disease has become clear. miRNAs represent a novel class of targets for therapeutic and diagnostic development, currently not fully exploited by the pharmaceutical and biotechnology industries. Cambridge Healthtech Institute’s Fifth Annual microRNA in Human Disease and Development meeting is specifically designed to address the role of miRNA in human development and disease, and to explore the impact of this new research for drug and diagnostic development. The meeting will cover progress in identifying human miRNA, technologies used for miRNA profiling, and the latest research in linking miRNA to human disease. Opportunities for using miRNA as diagnostic biomarkers and a novel class of targets for therapeutic development will be explored.
CHI’S THE CHALLENGE OF ANTIBACTERIAL DRUG DEVELOPMENT by Robert Black — last modified 10-08-08 05:13 AM: Resistant bacterial strains are becoming an increasing challenge for the pharmaceutical industry. There is a growing need to develop novel defense mechanisms and novel strategies to treat bacterial infections. In recent years, scientists have focused increasingly on developing novel concepts and improving leads to overcome the challenge of resistance. The interaction of biology and chemistry is key to the solution of this problem.
CHI’S NEXT-GENERATION SEQUENCING by Robert Black — last modified 10-08-08 05:13 AM: Next-generation sequencing is driving growth within the basic and biomedical research community as rapidly as the bases are being sequenced. All agree however, with the implementation of any new technology there is a balancing act of cost-quality-quantity. What is your sequencing goal? The potential applications are as numerous as the samples to be analyzed. Each next-gen platform is optimized for specific sequencing applications. Cambridge Healthtech Institute’s 3rd Annual Next-Generation Sequencing offers an unparalleled opportunity to compare and contrast the next-generation sequencing platforms to best suit your research needs.
CHI’S COMPREHENDING COPY NUMBER VARIATION by Robert Black — last modified 10-08-08 05:13 AM: All agree that copy number variation (CNV) contributes substantially to human genetic diversity. But to what extent? The resulting applications of newly developed whole-genome scanning technologies have catalyzed the appreciation of CNV in the genetic community. The range of these promising new technologies will, for the first time, allow scanning of the entire human genome for CNV in a single experiment. As these genome-wide scanning techniques become more widely used in diagnostic laboratories, the major challenge is how to accurately interpret which submicroscopic genomic imbalances are pathogenic in nature and which are benign.
CHI’S QUANTITATIVE PCR by Robert Black — last modified 10-08-08 05:13 AM: PCR’s sensitivity, specificity, and simplicity has revolutionized molecular biology in basic, industrial, and clinical settings. Technologies abound including quantitative PCR (qPCR), multiplex qPCR, real-time PCR, and reverse transcription quantitative PCR (RT-qPCR). Your technology selection is determined by the source of nucleic acid. However, complexities arise because of multiple assays, numerous protocols, abundant sources, lack of assay standardization, differences in sample processing, ineffective use of controls, normalization methods, and quality control management. Researchers face challenges in reliability, relevance, and reproducibility. Learn from savvy, seasoned researchers as they share their real-world experiences, applications, and results at Cambridge Healthtech Institute’s 5th Annual Quantitative PCR.
CHI’S ELECTRONIC DATA IN CLINICAL TRIALS by Robert Black — last modified 10-08-08 05:13 AM: New technology is available and being created everyday to make the collection, correction and assessment of data from clinical trials more efficient. How do you decide which technology to use and when to use it? What are the common problems with implementation and how do you resolve them. This inaugural conference is being organized to address these issues.
CHI’S THE GREENING OF PHARMA by Robert Black — last modified 10-08-08 05:13 AM: This premier CHI “Greening of BioPharma” Conference creates a unique forum bringing together, in one place, BioPharmaceutical company Real Estate Executives, Engineers, and Laboratory and Manufacturing Facilities Management Executives and Senior Managers with leading BioPharmaceutical laboratory and manufacturing facilities architects, construction firms, biopharmaceutical process design and systems companies and equipment vendors to define the future of “The Greening of BioPharma”. This conference will address the specialized issues and challenges unique to the Biotech and Pharmaceutical industries and how leading companies have met these challenges.
IMPACT Continuous Improvement Seminar by SyntexMgmtSystems Inc — last modified 09-24-08 08:27 AM: Join local Operational Risk stakeholders in observing "real life" experiences of Energy, Chemicals, Healthcare, Utility and Process Manufacturing businesses.
Chemical Control With Electrons and Photons by Ivanka Angelova — last modified 09-24-08 08:31 AM: Chair: Professor Petra Swiderek, Bremen Uni. (DE). Grants are available for young researchers to cover the conference fee and travel costs. Registration deadline: 17 Sept 2008. Topics: ·Chemical Control using ultrashort light pulses ·Chemical Control using low-energy electrons ·Chemical Control at the nanoscale with STM ·Plasma processing and nanofabrication ·Chemical control of biomolecules
Protein Purification: Principles & Practice by Robert Black — last modified 10-08-08 05:14 AM: A 5 ½ day hands-on laboratory course in which participants will learn skills to effectively design separation and purification strategies for downstream processing. This course uses the remarkable Green-Fluorescent Protein (GFP), a novel marker for gene expression, as the source material. While this is a general course applicable to all proteins, we use GFP as a highly effective visual teaching tool. More than 1200 scientists from around the world have strongly recommended this intensive course as an opportunity to develop protein research and analytical skills in a retreat setting. Participants work hard, identify and solve problems in the lab and enjoy camaraderie and good food and drink with colleagues. This five and one half day laboratory course covers a wide variety of conventional methods for protein isolation, purification, and characterization. The course format integrates hands-on laboratory exercises with classroom lectures, demonstrations, study breaks, and short take-home assignments.
Improving China Drug Development Team Performance: Essential Partnering Strategies, Skills and Processes by Robert Black — last modified 10-08-08 05:25 AM: The purpose of this seminar is to enable participants to improve global team management and communications in their own drug development project teams. The program focuses in particular on strengthening partnering relationships among pharmaceutical companies and the Contract Research Organizations (CROs). Chinese drug development global team success depends as much on effective management and communications as it does on excellent science and technology.
Open Learning and Workshops in Analytical Chemistry by Lorraine Hart — last modified 10-08-08 05:29 AM: Broaden your analytical skills portfolio and study at a time and in a place convenient to yourself. The open learning courses involve 10 weeks study using ACOL texts, and completion of two written assignments. You will have access to a tutor on-line who can help and advise. The course finishes with a 3-day practical workshop in a university laboratory. There are a wide range of techniques to choose from, and courses can be built up to achieve the Edexcel Professional Development Certificate in Analytical Chemistry. The courses provide a sound knowledge of the basic principles of analysis, an understanding of the instrumentation involved and the opportunity to become familiar with practical techniques. They will useful to those planning to move into new areas of analysis, or who need a better understanding of techniques used in their work, and also to those returning to work after a career break.
Organic Process Research & Development by Sue Parsons — last modified 10-08-08 05:22 AM: This conference brings together chemists and engineers from all parts of the world to discuss issues related to synthetic route design, development and optimisation and the scale-up of these processes. The invited speakers are selected to emphasise their companies approach to these issues with detailed case studies.
Polymorphism & Crystallisation by Sue Parsons — last modified 10-08-08 05:22 AM: This 2 day conference focuses on case studies from process chemists and engineers on chemical development issues which impact the ability to routinely manufacture chosen crystalline forms. Experts in the field of polymorphism and crystallisation also give lectures on troubleshooting and problem solving, as well as giving an insight into new techniques of value for the future.
Process Analytical Technology (PAT) in Organic Process R&D by Sue Parsons — last modified 10-08-08 05:21 AM: This Conference is dedicated to process chemistry and organic synthesis (contrasting to previous PAT conferences and symposia which have been predominantly formulation focused). With an emphasis on the science and technology associated with the synthesis and manufacture of active pharmaceutical ingredients (APIs), the aim is to showcase the use of PAT as a tool for increasing process understanding, robustness, reproducibility and efficiency in API manufacture, both in development and commercial production. Regulatory and QA issues will be touched upon where appropriate.
BioProcess International Conference and Exhibition by Daniel Fishman — last modified 08-04-08 06:34 AM: Building on the success of the past four years, an all-new program has been developed for 2008 by expert end-users together with the IBC research team. This year the agenda focuses unwaveringly on methods to reduce time to market and cost of goods, to dramatically accelerate development of robust processes, to achieve higher than ever yields from cell culture, and to break through the downstream bottleneck. This in-depth program allows you to choose from over 110 presentations from industry leaders as well as emerging, small- to medium-sized companies. Customize your own BPI experience to meet your needs as well as gain a comprehensive look at today's industry.
Infrared Spectral Interpretation, Special Topics by Daniel Fishman — last modified 08-04-08 06:21 AM: Two sessions of 3.5 hours each on October 6 and 7. Intermediate level Infrared interpreters who want to hone their skills and experts looking for a refresher will learn how to interpret the spectra of molecules with complex spectra by viewing many reference spectra and interpreting unknown spectra in class with the instructor’s guidance. The spectra of economically important functional groups will be emphasized.
Infrared Spectral Interpretation, Intermediate by Daniel Fishman — last modified 08-04-08 06:23 AM: Two sessions of 3.5 hours each on September 22 and 23. Building on the basics presented in "Infrared Spectral Interpretation, Basic", this course offers a detailed look at how to tackle the spectra of complex molecules. The course begins with a complete discussion of how molecules absorb infrared radiation, enabling attendees to fully understand the source of all the features they see in a spectrum. Then, the spectra of complex molecules such as alkenes, ethers, aldehydes, carboxylic acids, amides, and amines are pulled apart and analyzed in detail. Attendees interpret many unknown spectra in class with the help of the instructor to enhance learning.
Infrared Spectral Interpretation, Basic by Daniel Fishman — last modified 08-04-08 06:16 AM: Three sessions of 2.5 hours each on September 8, 10, and 12. An ideal course for the new or occasional infrared interpreter. Learn how to integrate all the information in a spectrum to successfully identify unknowns and mixture spectra. Learn the strategies to help make interpreting spectra faster and easier. Reference spectra of many economically important molecules are analyzed in detail. Attendees interpret many problem spectra in class and as homework under the instructor’s guidance.
Fourier Transform Infrared Spectroscopy by Daniel Fishman — last modified 08-04-08 06:11 AM: Three sessions of 2.5 hours each on September 8, 10, and 12. Learn how to use FTIR to solve on-the-job problems quickly and efficiently. Anyone who performs chemical analysis needs to know about FTIR. Regardless of which industry you work in, if you need to identify the molecules in a sample, you will benefit from this course. If you already use FTIR, you will see how to perform your analyses faster and cheaper and learn to optimize spectral quality while minimizing analysis time.
Effective Technical Writing (English as a Second Language version) by Daniel Fishman — last modified 08-04-08 06:08 AM: Five sessions of 90-minutes each on October 20, 27, November 3, 10 and 17. Improve your professional writing skills in this interactive workshop. This class is specifically designed for researchers, technical professionals, and managers who want to enhance their professional success by writing effectively and persuasively. Class size is limited to 20 participants to ensure individual attention. You are encouraged to bring samples of your own writing along with technical writing samples (such as scientific papers, reports, reviews, etc.) that you aspire to write. In addition, the instructor will confer with students about the writing assignments they complete during the course. Each student will be able to print a comprehensive course workbook.
Pharmacokinetics and Pharmacodynamics for Chemists by Daniel Fishman — last modified 08-04-08 06:05 AM: Six sessions of 75-minutes each on October 9, 16, 23, 30, November 6 and 13. This course presents the fundamentals of Pharmacokinetics and Pharmacodynamics as they apply to the chemical structure of drugs. There will be specific discussion of the role of medicinal chemistry in the drug discovery process, how chemical structure affects the absorption, distribution, metabolism and excretion (ADME properties) of drugs and also drug affinity and efficacy (Pharmacodynamics). By the end of this course students should be able to understand the role of the medicinal chemist on various iterations of teams involved in drug discovery and development. This course is centered on gaining an understanding of in vitro PK assay data (Caco-2, MDCK, PAMPA, microsomes, hepatocytes etc) to predict in vivo PK and optimize drug ADME properties.
A Pharmacology Primer for Chemists by Daniel Fishman — last modified 08-04-08 06:01 AM: Six sessions of 75-minutes each on October 8, 15, 22, 29, November 5 and 12. This course is designed to help chemists understand basic pharmacological principles and the extension of those principles into therapeutic medicine. By the end of this course students should be able to use pharmacology to assess structure-activity data on molecules in biological systems and to see relationships between chemical structure and drug affinity and efficacy.
Principles of Analytical Chemistry by Daniel Fishman — last modified 08-04-08 05:58 AM: Three 2.5 hour sessions held October 8, 10 and 14. An introduction to the science of making chemical measurements. The course begins with the fundamentals of gathering information and samples. How to quantify and minimize measurement error is covered next with an introduction to the elementary statistics needed to understand chemical measurements. The principles of how chromatographs achieve chemical separations are explained with an eye towards helping users optimize their analyses. The principles of spectroscopy are presented and are the basis for discussions of how FTIR and UV/Vis spectrometers work and are used. In-class exercises and homework will be used to increase retention of knowledge.
High Performance Liquid Chromatography Basics by Daniel Fishman — last modified 08-04-08 05:55 AM: Seven sessions of 60-minutes each on September 26, October 3, 10, 17, 24, 31 and November 7. This course will help you gain a sound working knowledge of basic high performance liquid chromatographic principles and develop a greater understanding of theoretical and practical relationships. Build the expertise you need to choose optimized column parameters, detector selection, and separation mechanism for the examination of complex mixtures, and in the end, improve your on-the-job performance. This course is ideal for R&D scientists and technicians or anyone who uses HPLC, and wishes to have a solid theoretical and practical background in this technique.
Gas Chromatography Basics by Daniel Fishman — last modified 08-04-08 05:26 AM: Seven sessions of 60-minutes each on September 26, October 3, 10, 17, 24, 31 and November 7. This course will help you to gain a sound working knowledge of basic gas chromatographic analysis, principles, and procedures and enable you to develop a greater understanding of theoretical and practical relationships. Throughout the seven, one-hour sessions of this course, you will build the expertise you need to choose optimum parameters for separating species present in complex mixtures, and in the end, increase your on-the-job efficiency.
Modern HPLC in Pharmaceutical Analysis by Daniel Fishman — last modified 08-04-08 05:24 AM: Six sessions of 90-minutes each on September 23, 30, October 7, 14, 21 and 28. Improve your overall HPLC skills set – topics covered include: advanced concepts in reversed-phase LC; best practices in instrument operation and troubleshooting; column selection, ICH purity testing, and method development; migrating methods to Fast LC and ultra-high-pressure LC; and novel approaches in pharmaceutical analysis. Registrants will receive a free copy of Modern HPLC for Practicing Scientists by Michael Dong. This easy-to-use reference has received eight 5-star reviews on Amazon.
From Beaker to Barrel: Chemical Engineering for Chemists by Daniel Fishman — last modified 08-04-08 05:21 AM: Five sessions of 90-minutes each on September 19, 26, October 3, 10, and 17. Learn how to apply chemical engineering knowledge to further your bench-grade process and understand important chemical engineering principals including thermodynamics, material balance, reactor design, and more. This course will be useful for those who need to negotiate and interact with chemical engineers and who need to appraise the industrial feasibility of their newly conceived chemical process.
Essentials of Chemistry by Daniel Fishman — last modified 08-04-08 05:19 AM: Eight sessions of 90-minutes each on September 18, 25, October 2, 9, 16, 23, 30 and November 6. This time-tested, but recently updated course is designed to give non chemists, and chemists in need of review, an understanding of basic and fundamental chemical principles. The essential, overarching themes of chemistry will be explored through the use of modern contextual examples. Registrants for this course will receive the textbook, Chemistry in Context.
Mass Spectroscopy Basics by Daniel Fishman — last modified 08-04-08 05:17 AM: Seven sessions of 75-minutes each on October 22, 29, November 5, 12, 19, 26, and December 3. This course will help you to gain a sound working knowledge of basic mass spectroscopic analysis principles and procedures and enable you to develop a greater understanding of theoretical and practical relationships. Throughout the seven sessions, you will build the expertise needed to choose optimum ionization and mass analysis parameters and techniques useful in the interpretation of mass spectra from organic compounds. In the end, these tools will increase your on-the-job efficiency.
Mass Spectroscopy Basics by Daniel Fishman — last modified 08-04-08 05:15 AM: Seven sessions of 75-minutes each on September 17, 24, October 1, 8, 15, 22, 29. This course will help you to gain a sound working knowledge of basic mass spectroscopic analysis principles and procedures and enable you to develop a greater understanding of theoretical and practical relationships. Throughout the seven sessions, you will build the expertise needed to choose optimum ionization and mass analysis parameters and techniques useful in the interpretation of mass spectra from organic compounds. In the end, these tools will increase your on-the-job efficiency.
Stimuli-Responsive Polymeric Films and Coatings by Daniel Fishman — last modified 08-04-08 05:12 AM: Six sessions of 90-minutes each on September 9, 16, 23, 30, October 7, and 14. Current advances in polymer chemistry and polymeric coatings have resulted in a rapid development of a new area of “smart” materials and polymers. They play the most significant role due to their resemblance to biological systems and numerous research efforts focused on mimicking the bio-world. This course will give you an advanced understanding of the creation, design, and use of these intelligent polymeric materials.
Essentials of Organic Chemistry by Daniel Fishman — last modified 08-04-08 05:09 AM: Five sessions of 90-minutes each on November 3, 10, 17, 24 and December 1. Have you been away from organic chemistry for a while and need a review of the basics? This course will renew your knowledge of the basics of organic chemistry by reviewing nomenclature, oxidation reduction, typical reactions of functional groups from a mechanistic perspective, stereochemistry, and medicinal chemistry.
Essentials of Organic Chemistry by Daniel Fishman — last modified 08-04-08 05:08 AM: Five sessions of 90-minutes each on September 8, 15, 29, October 6, and 20. Have you been away from organic chemistry for a while and need a review of the basics? This course will renew your knowledge of the basics of organic chemistry by reviewing nomenclature, oxidation reduction, typical reactions of functional groups from a mechanistic perspective, stereochemistry, and medicinal chemistry.
Effective Technical Writing by Daniel Fishman — last modified 08-04-08 05:05 AM: Five sessions of 90-minutes each on November 3, 10, 17, 24, and December 1. Improve your professional writing skills in this interactive workshop. This class is specifically designed for researchers, technical professionals, and managers who want to enhance their professional success by writing effectively and persuasively. Class size is limited to ensure individual attention. You are encouraged to submit samples of your own writing along with technical writing samples (such as scientific papers, reports, reviews, etc.) that you aspire to write.
Effective Technical Writing by Daniel Fishman — last modified 08-04-08 02:30 AM: Five sessions of 90-minutes each on September 8, 15, 29, October 6, and 20. Improve your professional writing skills in this interactive workshop. This class is specifically designed for researchers, technical professionals, and managers who want to enhance their professional success by writing effectively and persuasively. Class size is limited to ensure individual attention. You are encouraged to submit samples of your own writing along with technical writing samples (such as scientific papers, reports, reviews, etc.) that you aspire to write.
The Future of HR in the Chemical Industries by Katie Poelking — last modified 07-31-08 02:54 AM: Experts are predicting massive talent shortages within the near future. Both talent shortages and an aging workforce are forcing the chemical industry to face major obstacles when implementing human resource programs. By recruiting and hiring select professionals, chemical companies can build a workforce capable of exceeding business goals. Furthermore, training and development programs can foster talent within your organization to create a corporate culture that values employees. This conference will bring together decision makers from Fortune 500 companies leading the way in successful human resource strategies. Through case studies, participants will gain insight on best practices in recruiting, leadership, and employee engagement programs. Interactive panel discussions will provide attendees a platform to delve deeper into retention and staffing issues and how to build a corporate culture that fosters growth. In a highly interactive environment, a select group of delegates will have the opportunity to network, benchmark, and share ideas on how their company successfully finds, grows, and retains a highly skilled workforce.
The 12th International Electronic Conference on Synthetic Organic Chemistry by Daniel Fishman — last modified 07-24-08 08:11 AM: This will be the 12th meeting of ECSOC since 1997. All accepted papers will be posted as websites during 1–30 November 2008. Discussions in the form of e-mail exchanges or bulletin boards will be possible. The ECSOC-12 Proceedings will be published later online and as a CD-ROM edition. Posters presented at ECSOC-12 may be considered as preliminary communications of research results (or review papers) and may be published in another form later in any standard journal. At the authors discretion, contributions will be removed from the web-site after the end of the conference and not included in the online and CD-ROM ECSOC-12 Proceedings as a book (ISBN: 3-906980-20-0, to be published at the end of conference). Authors are invited to publish their papers subsequently in Molecules (http://www.mdpi.org/molecules).
Organic Reactions & Syntheses by Daniel Fishman — last modified 07-21-08 03:37 AM: Due to popular demand for a conference dedicated solely to “hardcore” organic synthesis, conference chairs Nick Magnus, Research Advisor in process research at Eli Lilly, and Mo Movassaghi, Assistant Professor of Chemistry at MIT, have invited both academic and industrial speakers to present chemistry in the areas of catalysis, heterocyclic chemistry, asymmetric synthesis, methodology, and total synthesis. The conference will explore strategies that enable the preparation of new pharmaceutical agents, molecular probes, complex natural products, and organic materials. Speakers from major pharmaceutical companies will present case studies that detail the techniques they employed to solve synthesis problems to enable the clinical evaluation of new medicines.
Topics and Tactics in Current Drug Design by Daniel Fishman — last modified 07-21-08 03:33 AM: The “Topics and Tactics in Current Drug Design” conference will be chaired by Dr. Nicholas A. Meanwell, Executive Director of Discovery Chemistry at Bristol-Myers Squibb Research and Development, and Dr. Milind S. Deshpande, Executive Vice President of Research & Chief Scientific Officer of Achillion Pharmaceuticals, Inc. The expeditious and successful development of drug candidates requires a detailed understanding of drug-target interactions and an appreciation for the many off-target sources of drug failure. This ACS Prospectives conference will look broadly at contemporary topics in drug design and discovery by exploring many of the problems commonly faced by medicinal chemists. Each session will emphasize fundamental aspects of drug design, providing comprehensive synopses of the kinds of tactics and strategies that have led to the optimization of drug-target interactions against the backdrop of enhancing drug safety and compound delivery in vivo.
Translational Biomarkers: Pathways to Phase II Survival by Daniel Fishman — last modified 07-21-08 03:27 AM: The first ACS ProSpectives conference on translational Biomarkers will be chaired by Dr. Lisa Gold, Executive Director of Merck, and Dr. Paul Galatsis, Associate Research Fellow of Pfizer. Together they have gathered a group of highly regarded pharmaceutical industry and academic scientists who will lecture and present case studies over the course of the two day program. The high attrition rates experienced in Phase II has multiple implications for drug discovery and the pharmaceutical industry in general. This conference is geared specifically for medicinal chemists and focuses on the pathways for developing translational biomarkers. These tools facilitate the translation of preclinical candidates into clinical programs with a greater degree of confidence and have the potential to increase the probability of their success.
Process Chemistry in the Pharmaceutical Industry by Daniel Fishman — last modified 07-21-08 03:25 AM: New conference chairs Pat Confalone of DuPont and Joseph Fortunak of Howard University have developed the 2008 program for the “Process Chemistry in the Pharmaceutical Industry” conference with an emphasis on process R&D and a look into how another industry navigates the issues of commercial ramp up and manufacturing. A number of case studies from the pharmaceutical industry will be given to highlight the challenges and rewards of discovering and developing commercial manufacturing processes for novel therapeutics. The engineering aspects of process R&D, including kinetics, process parameters, process analytical technology, and green chemistry, will also be explored.
PK/PD for Medicinal Chemists by Daniel Fishman — last modified 07-21-08 03:21 AM: Conference chairs Zheng Yang of Bristol-Myers Squibb and Ellen Q. Wang of Pfizer will present the 3rd annual ACS ProSpectives conference on pharmacokinetics (PK) and pharmacodynamics (PD). This conference is specifically designed for medicinal chemists and team leaders directly involved in the discovery and early development of new drugs who want to learn more about PK-PD and applying it to drug design.
ACS Short Course Circuit by Daniel Fishman — last modified 07-21-08 03:16 AM: Includes the following courses: Chemical Engineering for Chemists, Process Research in the Pharmaceutical Industry, Pharmacokinetics and Pharmacodynamics: Principles and Applications in Pre-Clinical Drug Development, Methods Development, Validation Procedures, and Conformity Assessment in the Analytical Laboratory, Drug-Like Properties in Drug Discovery, Statistical Analysis of Laboratory Data, Essentials of Medicinal Chemistry and Pharmacology, Laboratory Safety and Health, Toxicology: Principles and Applications, Chemical and Biological Mechanisms in Toxicology, Effective Technical Writing.
Polymer Chemistry: Principles and Practice by Daniel Fishman — last modified 07-21-08 03:07 AM: This six-day course is taught by five Virginia Tech professors and is designed for all education levels. Students can expect to learn about polymer synthesis, molecular weight determination, characterization of rheological and viscoelastic behavior; gain a better understanding of polymer structure and morphology, and mechanical testing; study elastomers, plastics, and fibers; learn from practical examples from fields of adhesion and composites; and understand the measurement of properties of polymers, which are then discussed as functions of chemical composition, molecular weight, topology, morphology, etc.
High Performance Liquid Chromatography: Fundamentals, Troubleshooting, and Method Development by Daniel Fishman — last modified 07-21-08 03:03 AM: This course is designed for beginners and intermediate-level users in HPLC who want practical laboratory experience. The lectures, supplemented by problems sets, slides, and video presentations, provide the fundamentals needed to understand the techniques and instrumentation involved in this powerful analytical tool. Key topics include: basic instrumentation for HPLC; detectors, including UV/VIS, photo diode array, mass spectrometer, and fluorescence; column selection and optimization, qualitative and quantitative analysis; and troubleshooting HPLC systems.
High Performance Liquid Chromatography: Fundamentals, Troubleshooting, and Method Development by Daniel Fishman — last modified 07-21-08 03:01 AM: This course is designed for beginners and intermediate-level users in HPLC who want practical laboratory experience. The lectures, supplemented by problems sets, slides, and video presentations, provide the fundamentals needed to understand the techniques and instrumentation involved in this powerful analytical tool. Key topics include: basic instrumentation for HPLC; detectors, including UV/VIS, photo diode array, mass spectrometer, and fluorescence; column selection and optimization, qualitative and quantitative analysis; and troubleshooting HPLC systems.
Gas Chromatography: Fundamentals, Troubleshooting, and Method Development by Daniel Fishman — last modified 07-21-08 02:57 AM: This course is designed for beginners and intermediate-level practitioners who want practical laboratory experience in gas chromatography .The lectures, supplemented by problem sets, slides, and video presentations, provide the fundamentals needed to understand the technique and instrumentation involved in this powerful analytical tool. At the end of the class, you will have mastered the fundamentals of GC, participated in five hands on laboratory sessions, performed reference and literature searches and learned specialized techniques based on your specific interests.
Gas Chromatography: Fundamentals, Troubleshooting, and Method Development by Daniel Fishman — last modified 07-21-08 02:50 AM: This course is designed for beginners and intermediate-level practitioners who want practical laboratory experience in gas chromatography .The lectures, supplemented by problem sets, slides, and video presentations, provide the fundamentals needed to understand the technique and instrumentation involved in this powerful analytical tool. At the end of the class, you will have mastered the fundamentals of GC, participated in five hands on laboratory sessions, performed reference and literature searches and learned specialized techniques based on your specific interests.
IBC Training Course: Production Process Deviation: Strategies for Investigation by Steve Garofalo — last modified 07-07-08 07:24 AM: Learn about methods of investigating the root and probable cause of deviations that occur in pharmaceutical and biopharmaceutical manufacturing, and hear case studies of actual investigations. Please visit www.IBCLifeSciences.com/courses for complete course agendas and the dates and locations for the more than 80 separate courses to be presented in the fall 2008 and spring 2009 terms.
IBC Training Course: Stability & Specifications for Biological and Biotechnology Derived Products by Steve Garofalo — last modified 07-07-08 07:24 AM: Details the technical, regulatory and quality practices necessary for setting specifications for a wide variety of biological and biotechnological products. Please visit www.IBCLifeSciences.com/courses for complete course agendas and the dates and locations for the more than 80 separate courses to be presented in the fall 2008 and spring 2009 terms.
IBC Training Course: Bioassay Method Development & Validation by Steve Garofalo — last modified 07-07-08 07:24 AM: Learn the steps needed to select, develop, optimize and validate biological assays to meet regulatory requirements in preclinical and clinical stages of biopharmaceutical manufacturing. Please visit www.IBCLifeSciences.com/courses for complete course agendas and the dates and locations for the more than 80 separate courses to be presented in the fall 2008 and spring 2009 terms.
CHI’S DRUG FORMULATION by Robert Black — last modified 07-06-08 09:12 AM: Drug Formulation This conference will focus on the development of novel drug delivery and formulation systems to create new medicines for the Pharmaceutical Industry. Maximizing bioavailability, improving manufacturability, and enhancing IP protection will be discussed. Industry case studies, posters and discussion groups will high-light advances in this important drug development area. Please join pharmaceutical experts for this in-depth exploration of how to optimize the science and refine the art of small molecule drug formulation. Topics may include, but are not limited to: * - High-Throughput Crystallization * - Polymorph & Salt Screening and Selection (HTP Methods) * - High-Throughput Stability & Solubility Testing * - HTE Formulation Design * - PAT in API and drug product manufacturing * - Powder Dispensing – Automation and Beyond * - Precipitation Rates and Super saturation Ratios * - Novel Formulation Strategies for Drug Delivery * - Advances through Robotics and Automation * - PAT in Formulation To ensure the quality of the program, all proposals will be reviewed by the Scientific Advisory Committee.
CHI’S GLP BIOANALYSIS COURSE # 1 by Robert Black — last modified 07-06-08 09:13 AM
CHI’S GLP BIOANALYSIS COURSE # 2 by Robert Black — last modified 07-06-08 09:13 AM
CHI’S BIOMARKERS EUROPE by Robert Black — last modified 07-06-08 09:14 AM: Biomarkers Europe 2008 offers a comprehensive program, covering all aspects of biomarker translation and implementation in the clinic. Drawing on the expertise of producing a diverse array of biomarker meetings, Biomarkers Europe will feature the best examples and case studies in all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline, including safety and efficacy assessment in drug discovery/development, biomarker translation from pre-clinical to clinical studies, biomarker validation and utility in clinical trials, and biomarker assay development and validation. www.healthtech.com
CHI’S PHARMACOGENOMICS NOW: MAXIMIZING BENEFIT/MINIMIZING RISK by Robert Black — last modified 07-06-08 09:14 AM: Pharmacogenomics is being implemented now and is already have an impact in the clinical setting and in healthcare. Employing a pharmacogenomics strategy with marketed drugs can mitigate risk by avoiding adverse events, allowing the identification of patients most likely to benefit from a drug, and thereby improving patient compliance and safety. Tangible benefits of pharmacogenomics and resequencing technologies will be presented, and the value of this approach will be demonstrated. The regulatory perspective will be covered from the US, Europe, and Canada. In the future, a confluence of diagnostic testing, drugs and information will be required to bring new medicines to market. This meeting will show how to apply pharmacogenomics to practice. www.healthtech.com
THE ASAP-CHI BIO-PHARM ALLIANCE SUMMIT by Robert Black — last modified 07-06-08 09:14 AM: The model for new pharmaceutical product development is changing rapidly and your company’s strategy must respond, whether you are a large pharmaceutical company, or an emerging biotech company. Alternative sourcing programs are emerging. Alliances are becoming more and more central to new product development as alliance centric external development programs emerge. Movements towards better integration of business development and alliance management functions and integration of alliances and acquisition, are also transforming how companies are finding, evaluating, structuring and negotiating deals and working with their external partners to develop new products and commercialize those products. www.healthtech.com
CHI’S BRIDGING THE BUSINESS DEVELOPMENT ALLIANCE MANAGEMENT INTERFACE by Robert Black — last modified 07-06-08 09:14 AM: The model for new pharmaceutical product development is changing rapidly and your company’s strategy must respond, whether you are a large pharmaceutical company, or an emerging biotech company. Alternative sourcing programs are emerging. Alliances are becoming more and more central to new product development as alliance centric external development programs emerge. Movements towards better integration of business development and alliance management functions and integration of alliances and acquisition, are also transforming how companies are finding, evaluating, structuring and negotiating deals and working with their external partners to develop new products and commercialize those products. Immediately followed by The ASAP-CHI Bio-Pharm Alliance Summit, be part of these premier events! www.healthtech.com
CHI’S BRIDGING PHARMA & IT by Robert Black — last modified 07-06-08 09:14 AM: Drawing on the reputation and expertise of Bio-IT World and Cambridge Healthtech Institute, Bridging Pharma and IT is one of the most influential meetings in North America. It is the only meeting to feature case studies of IT/Science paired discussions that provide insights into cross-domain partnering with an organization's end users and IT. The 2008 agenda will focus on tactics and processes that organizations can effectively and efficiently use to minimize communication gaps between scientists, researchers, and information technology professionals in building solutions and capabilities, utilizing data models and their validation, and integrating drug targets and compounds. A number of joint presentations from pairs of end users and IT and informatics partners will provide indispensable guidance for surmounting challenges and delivering results. www.healthtech.com
236th ACS National Meeting & Exposition by Thea Osinski — last modified 06-23-08 02:34 AM: The 236th ACS National Meeting & Exposition will take place August 17-21, 2008 in Philadelphia, Pennsylvania. Events will be held at the Pennsylvania Convention Center and hotels around the city. The technical program will feature original programming hosted by 31 technical divisions, one secretariat, three committees, and the ACS president and will include thematic programming around "Chemistry for Health: Catalyzing Translational Research."
CHI’S HIGH-CONTENT ANALYSIS 2009 by Robert Black — last modified 06-17-08 07:42 AM: www.healthtech.com
CHI’S IMAGING WEEK by Robert Black — last modified 06-18-08 06:17 AM: • In Vivo Molecular Imaging www.imaging-week.com
CHI’S PORTFOLIO MANAGEMENT by Robert Black — last modified 06-17-08 07:41 AM: Our 2008 forum will be built with guidance from the PSS advisory board. It will include novel case studies and perspectives from thought leaders who have real-world perspectives to share. www.healthtech.com
CHI’S STRATEGIC RESOURCE MANAGEMENT by Robert Black — last modified 06-18-08 06:27 AM: Each year the Strategic Resource Management attracts over 100 participants who help lead their organization’s resource management strategy. Our 2008 meeting will build on last year’s successful event with novel case studies and perspectives from thought leaders. www.healthtech.com
CHI’S MASTERING PROCESS CHEMISTRY by Robert Black — last modified 06-17-08 07:41 AM: The Fourth Annual Mastering Process Chemistry conference returns to Philadelphia in November, 2008. Through pharmaceutical industry case studies, roundtable discussions and panel sessions, this year’s program will feature new bio and organic catalysis, ways to incorporate and maintain chirality and better automation and high-throughput technologies for process optimization. The meeting will also feature continuous processing applications and PAT considerations for the scale-up synthesis of small molecule therapeutics. www.healthtech.com
CHI’S POST-APPROVAL DRUG SAFETY STRATEGIES by Robert Black — last modified 06-18-08 06:31 AM: Improving products’ effective clinical safety will increase the industry’s fundamental value proposition to patients, healthcare providers, payors and regulators. The program will focus on pharmacovigilance program implementation and specific strategies and approaches to creating true value from a peri- and post-approval drug safety program. Drug safety programs and monitoring and the approach of this conference are not to look at safety in the silos of early-phase safety or post-approval safety but to view safety holistically, across the lifecycle, especially at the transition from approval to broader use in the marketplace. www.healthtech.com
CHI’S ADAPTIVE CLINICAL TRIALS by Robert Black — last modified 06-17-08 07:40 AM: Scope of conference – 2007 was a big year for both the implementation and recognition of the value of adaptive trial designs in drug development. This was evidenced by: • Large pharmaceutical organizations implementing and reporting time and cost savings associated with the use of adaptive trial designs • EMEA’s finalization and publication of their “Reflection Paper on Methodological Issues in Confirmatory Clinical Trials Planned with Adaptive Design” (CHMP/EWP/2459/02) last October • EMEA/EFPIA workshop on adaptive designs in confirmatory clinical trials conducted in Dec. 2007 www.healthtech.com
CHI’S ANTIBODIES EUROPE by Robert Black — last modified 06-17-08 07:40 AM: Although therapeutic antibodies have come a long way in the past several years, many problems still exist in the production and use of these complex molecules. The negative qualities of these proteins, including immunogenicity, delivery difficulties, and the high cost of production, among others, have made the outcomes of their production and use less than satisfactory. In order to improve or eliminate these negatives, it is critical to find new ways to engineer antibodies, new antibody alternatives (such as mimetics, fragments, etc.) and novel ways to scale up production to provide large amounts of these proteins in a cost-effective way. This conference will present the latest data on how to achieve these improved results and the research data necessary to apply the solutions to your laboratory’s efforts. www.healthtech.com
CHI’S DISCOVERY ON TARGET by Robert Black — last modified 06-18-08 06:32 AM: • RNAI For Screening • Kinase Inhibitors • HDAC Inhibitors: Targeting Oncology & Beyond • Oncology Drug Targets-Managing The Portfolio RNAI For Therapeutics • RNAI For Therapeutics www.DiscoveryOnTarget.com
CHI’S PROTEIN EXPRESSION EUROPE by Robert Black — last modified 06-17-08 07:39 AM: Great strides have been made in the expression of proteins for structure and characterization studies, as well as for therapeutics and diagnostics. However, with these strides have come new obstacles. Higher throughput expression and purification, as well as more flexible expression systems and techniques are in even greater demand now to support the needs of the research pipeline. It has become even more important to prevent problems in protein expression by wise choices in data analysis well before the task goes into the laboratory. This conference will explore the newest data and innovations relating to the expression and characterization of proteins for biological understanding and therapeutics, as well as strategies to make the eventual expression of these proteins more effective, efficient and trouble-free. www.healthtech.com
CHI’S ACCELERATING PROOF OF CONCEPT by Robert Black — last modified 06-17-08 07:38 AM: With increasing resource pressure, drug developers need to make more effective and informed go/no-go decisions as early as possible in the drug development process. This allows the best compounds to move ahead with adequate resource support. By doing more of the right experiments, earlier in the pre-clinical discovery and development process, drug developers will face fewer surprises as drugs move into the more expensive later stages of the development process. Biomarkers, FDG-PET Imaging, Gene Expression, Metabolic Screening, Protein Tomography and other advanced tools are increasingly being used for early confirmation of a drug development candidate’s ability to reach a target, confirm bioavailability and impact on a target or pathway, to enable an earlier, more effective, decision making processes. Leading drug discovery and development companies are increasingly reorganizing their drug development process and programs to take advantage of these new tools and techniques to improve drug development pipeline productivity and focus resources on the most promising candidates. www.healthtech.com
CHI’S DRUG REPOSITIONING 2008 by Robert Black — last modified 06-17-08 07:34 AM: Drug repositioning efforts create alternative development routes for compounds that failed to meet their clinical endpoint but met safety milestones. Repositioning approaches can also be employed for existing drugs to identify alternative uses or new indications. This can involve screening a compound against new targets, or investigating a given target against new indications. Repurposing or repositioning represents both a faster and less risky route to development. A discussion of how to gain access to data, and overcome organizational boundaries will be covered. Case studies that best utilize available technologies to form a comprehensive picture of a compound or target’s potential value will be explored, and will shed light on how to exploit repositioning towards unmet medical need and expanding the drug pipeline. www.healthtech.com
CHI’S BIOMARKER DISCOVERY SUMMIT 2008 by Robert Black — last modified 06-18-08 06:25 AM: • Fourth Annual Genomic Biomarkers • Sixth Annual Protein Biomarkers • Ninth Annual Metabolic Biomarkers www.BiomarkerDiscoverySummit.com
CHI’S EXPLORING NEXT GENERATION SEQUENCING by Robert Black — last modified 06-18-08 06:20 AM: Next-Generation sequencing is alive, thriving, and driving discovery. As costs come down and ease increases these new massively parallel high-throughput sequencing platforms are infiltrating multiple aspects of traditional biological research. However, each next generation sequencing platform best lends itself to specific sequencing goals. Cambridge Healthtech Institute’s Exploring Next Generation Sequencing offers an unparalleled opportunity to compare and contrast these next generation sequencing platforms to best suit your research needs. www.healthtech.com
CHI’S INTEGRATIVE DATA ANALYSIS by Robert Black — last modified 06-17-08 07:37 AM: Genomic research has become a discipline to be integrated with clinical medicine. Currently, genomic technologies allow for the simultaneous quantification of gene activity in tissues/cells from patients. Will these genomic technologies make it possible to develop personalized medicine leading to a more accurate diagnosis and prognosis for every patient and subsequently a tailored treatment strategy? With the addition and linkage of clinical parameters disparate data points are created. All agree data integration is crucial. Join innovators from technological platform development, biostatistical analysis, biological, pharmaceutical, and clinical research as they share their experiences and insights for Integrative Data Analysis: Is Personalized Medicine at Hand? www.healthtech.com
CHI’S NEXT-GENERATION SEQUENCING DATA ANALYSIS by Robert Black — last modified 06-17-08 07:37 AM: As new sequencing platforms are capable of generating gigabytes of data in a single sequence run - leading to terabytes of data in an experiment; data storage, transfer, and analysis will unquestionably be the rate limiting steps in turning the new sequence data into knowledge. CHI’s Inaugural Next-Generation Sequencing Data Analysis convenes engineers who are developing the sequencing platforms, biological researchers who are designing and running the experiments, biosatiations who are analyzing and interpreting the data, and software developers who are managing and storing the data. Each specialty provides perspectives and must be integrated into a cohesive, comprehensive team to decipher the sequencing data deluge. www.healthtech.com
CHI’S MULTIPLEXED GENOMIC TOOLS: TARGETING THE MISSING LINKS BETWEEN HEALTH AND DISEASE by Robert Black — last modified 06-17-08 07:36 AM: Completing the sequence of human and other genomes will soon elucidate the precise location and base sequence of every gene in a reference genome. This reference allows for rapid characterization of polymorphisms across populations. It also enables molecular fingerprinting technologies to permit identification of the precursors and consequences of normal and pathological changes in gene expression. The challenge facing current biological research is effective matching of the tool to the target. Learn from seasoned and savvy researchers who share their experience and of challenges piecing together the biological puzzle of health and disease at Cambridge Healthtech Institute’s 4th Annual Genomic Tools: Targeting the Missing Links between Health and Disease. www.healthtech.com
CHI’S DRUG DEVELOPMENT CHINA by Robert Black — last modified 06-17-08 07:35 AM: Sought by most international pharmaceutical and biotechnology companies, China has become a partner of choice for international biopharmaceutical companies. In order to minimize unnecessary expenses, time and risk involved in R&D, companies have found an effective solution and worthy partner in this low-cost region populated by a highly-skilled drug discovery and development talent pool. In addition, due to its growing western-educated middle class, China presents valuable commercial opportunities for pharmaceutical and biotechnology companies. www.healthtech.com
CHI’S BACULOVIRUS TECHNOLOGY by Robert Black — last modified 06-17-08 07:33 AM: The Baculovirus Technology meeting will bring together experts who are achieving breakthroughs and clinical success. Innovative approaches to tackling the problems of increasing protein expression levels and humanizing the N-glycosylation pathway will be addressed, along with case studies from industry leaders. www.healthtech.com
CHI’S OPTIMIZING CELL CULTURE DEVELOPMENT by Robert Black — last modified 06-17-08 07:33 AM: Optimizing Cell Culture Development will include talks from industry experts that address critical issues in an atmosphere that encourages sharing, learning, and networking. The agenda will again feature small-group breakout discussions that will provide the opportunity to discuss important topics with your peers in a fun and collegial setting. In addition, case studies will be presented that shed light on improving yield while maintaining product quality within the regulatory framework. www.healthtech.com
CHI’S CANCER DIAGNOSTICS: NEXT GENERATION MOLECULAR TECHNOLOGIES by Robert Black — last modified 06-17-08 07:32 AM: Advances in molecular diagnostics has enabled the detection of early stage tumors that will lead to greater success rates with intervention and treatment. Tests are being commercialized that employ a variety of approaches utilizing gene expression, serum biomarkers, and circulating tumors cells to capture information early for non-invasive screening of selected populations. Technologies to resolve and isolate the earliest stages of disease can be used in some cases in combination with imaging techniques to differentiate between benign vs. malignant tumors. The potential for these assays to greatly improve patient survival and care is historic and opportune and will further allow the tracking of disease progression. www.healthtech.com
CHI’S ENABLING POINT-OF-CARE DIAGNOSTICS by Robert Black — last modified 06-17-08 07:32 AM: The POC diagnostics industry is rapidly expanding, and promises to answer the need for more integrated and immediate clinical results. Technologies are being developed that will integrate with the health information infrastructure to allow fast, accurate and easy-to-use assays. These can be used in global health and crisis response environments, as well as in clinical settings. Applications in stroke, respiratory disease, cardiac treatment will be featured that will take into consideration the unmet clinical need and the technology development that is unique to each application. The need for generating reliable data and reducing costs will be weighed against other requirements. www.healthtech.com
CHI’S SYSTEMS INTEGRATION IN BIODEFENSE by Robert Black — last modified 06-17-08 07:31 AM: At this year ’s Systems Integration in Biodefense meeting, we will hear from industry leaders about their strategy for meeting the needs of the community and bridging the technology gaps that still exist. New assays will be introduced that are highly multiplexed, integrated and field deployable. Technology developments in sample prep, signal transduction and amplification will be showcased, and specific examples of creating an integrated system will be presented. Dual-use application is an essential feature for products to have utility in biodefense and clinical settings. A discussion on getting products to market and facing commercialization, collaboration, and business challenges will be addressed. The meeting will be followed by the 2nd Annual Enabling Point-of-Care Diagnostics to elucidate the transition from biodefense to a clinical setting, and the tactical issues of implementation. www.healthtech.com
CHI’S THE IMMUNOTHERAPEUTICS & VACCINE SUMMIT by Robert Black — last modified 06-17-08 07:30 AM: • Novel Vaccines: Bridging Research, Development & Production • Advances in Cancer Vaccines • Clinical Risk Management & Safety for Vaccines www.TargetedImvacS.com
CHI’S CELLUTIONS SUMMIT by Robert Black — last modified 06-17-08 07:27 AM: Cells are potential solutions! Cambridge Healthtech Institute's Third Annual CELLutions SUMMIT is uniquely designed to explore the evolving field of next-generation cells, engineered 3D cellular models, and therapeutic cellular-in-human use. Scientific technological progress brings fundamental understanding and provides the foundation for more rapid advances toward the clinic. Targeted Topics: • Cell Sources • 3D Cellular Models • Cell Therapies • Five @ Five www.CELLutionsSUMMIT.com
RACI/NZIC Inorganic Chemistry Conference IC08 by chemweb — last modified 06-03-08 02:30 AM: The Royal Australian Chemical Society and the New Zealand Institute of Chemistry invite you to participate in IC08, to be hosted by the University of Canterbury, 14 - 18 December 2008, in Christchurch, New Zealand. The conference will cater for all fields of inorganic chemistry, from bioinorganic chemistry, through classic coordination and organometallic chemistry, to supramolecular and materials chemistry. Plenary speakers: Bob Grubbs - California Institute of Technology A.P. de Silva - Queen's University Belfast Chi-Ming Che - University of Hong Kong Joe Hupp - Northwestern University Franc Meyer - University of Gottingen Stay on after the conference and have a Christmas holiday seeing the sights of the South Island! Stranks Awards* and poster prizes will be awarded!
Melt Dispersion of Fillers for Nanocomposite Applications by Gregory Taounhaer — last modified 05-22-08 03:11 AM: The success of filler enhanced polymer nanotechnology is highly dependent on the extent of filler dispersion in the polymer matrix. However, many of us already experienced the difficulty of such a task. This e-training course will help to gain a better understanding of the key issues involved in filler dispersion and to use the knowledge gained to design successful nano-dispersion technology. Don't miss this opportunity to hear about nano-fillers dispersion best practices… It could prevent you from having to invest in a PhD internship and doing three years of research to achieve the same goal.
Frontiers in Chemical Sciences by wilfred sugumar Richards — last modified 04-12-08 03:24 AM: The birth centenary of Late Dr,S.V.Ananthakrishnan, former professor and head of department of chemistry Madras Christian College falls on 2nd October 2008. We conduct an International Conference “Frontiers in Chemical Sciences”during 2-4 October 2008. Please contact.Dr.R. Wilfred Sugumar , Head, Department of chemistry, Madras Christian College Chennai 600059, India for details e mail: wilfmcc@rediffmail.com
XIXth SLOVAK-CZECH SPECTROSCOPIC CONFERENCE by Peter Matus — last modified 04-10-08 01:28 PM: The XIXth Slovak-Czech Spectroscopic Conference (XIXth SCSC) is proceeding with a long term scientific cooperation between both spectroscopic societies. The meetings organized by the Czechoslovak Spectroscopic Society in the past and the continuation in the tradition of the Slovak Spectroscopic Conferences (SSC) will continue as joint events to the future. The last SSC took place in Spišská Nová Ves (Slovakia) in 2006. The aim of the XIXth SCSC is to bring together experts from universities, academia, official centers, various laboratories, and industry on a world-wide scale, to summarize the current progress in different areas of spectroscopy and to stimulate contacts and mutual exchange of experiences and ideas.
11th Bratislava Symposium on Saccharides by Jan Gajdos — last modified 03-17-08 02:23 AM: The scientific program of the Symposium will cover all aspects of chemistry, biochemistry, biology, and technology of carbohydrates and glycoconjugates.
75 Years of Polyethylene: Past Successes and Future Challenges by Geoffrey Mitchell — last modified 03-17-08 02:16 AM: A one-day meeting to mark the 75 years of scientific and technological development since the discovery of polyethylene by Reginald Gibson and Eric Fawcett on 27 March 1933. A series of presentations on the Discovery, Developments and Challenges of polyethylene together with the unique opportunity to visit the Plastics Exhibition in the Science Museum and see the original equipment used by Gibson and Fawcett in the discovery of polyethylene.
Organic Reactions & Syntheses by Daniel Fishman — last modified 02-13-08 01:31 PM: Due to popular demand for a conference dedicated solely to “hardcore” organic synthesis, conference chairs Nick Magnus, Research Advisor in process research at Eli Lilly, and Mo Movassaghi, Assistant Professor of Chemistry at MIT, have invited both academic and industrial speakers to present chemistry in the areas of catalysis, heterocyclic chemistry, asymmetric synthesis, methodology, and total synthesis. The conference will explore strategies that enable the preparation of new pharmaceutical agents, molecular probes, complex natural products, and organic materials. Speakers from major pharmaceutical companies will present case studies that detail the techniques they employed to solve synthesis problems to enable the clinical evaluation of new medicines.
Topics and Tactics in Current Drug Design by Daniel Fishman — last modified 02-13-08 01:24 PM: The “Topics and Tactics in Current Drug Design” conference will be chaired by Dr. Nicholas A. Meanwell, Executive Director of Discovery Chemistry at Bristol-Myers Squibb Research and Development, and Dr. Milind S. Deshpande, Executive Vice President of Research & Chief Scientific Officer of Achillion Pharmaceuticals, Inc. The expeditious and successful development of drug candidates requires a detailed understanding of drug-target interactions and an appreciation for the many off-target sources of drug failure. This ACS Prospectives conference will look broadly at contemporary topics in drug design and discovery by exploring many of the problems commonly faced by medicinal chemists. Each session will emphasize fundamental aspects of drug design, providing comprehensive synopses of the kinds of tactics and strategies that have led to the optimization of drug-target interactions against the backdrop of enhancing drug safety and compound delivery in vivo.
Translational Biomarkers: Pathways to Phase II Survival by Daniel Fishman — last modified 02-13-08 01:20 PM: The first ACS ProSpectives conference on translational Biomarkers will be chaired by Dr. Lisa Gold, Executive Director of Merck, and Dr. Paul Galatsis, Associate Research Fellow of Pfizer. Together they have gathered a group of highly regarded pharmaceutical industry and academic scientists who will lecture and present case studies over the course of the two-and-a half-day program. The high attrition rates experienced in Phase II has multiple implications for drug discovery and the pharmaceutical industry in general. This conference is geared specifically for medicinal chemists and focuses on the pathways for developing translational biomarkers. These tools facilitate the translation of preclinical candidates into clinical programs with a greater degree of confidence and have the potential to increase the probability of their success. This program is comprised of three sessions that address key areas of interest for the practicing medicinal chemist. They are:  Translatable target engagement biomarkers (imaging and non-imaging biomarkers)  Mechanism biomarkers, including safety  Clinical biomarkers, including disease biomarkers and regulatory acceptance In each session, four speakers will present on their research addressing and providing their prospective on the session topic. Real life examples will illustrate how the theoretical can be used to address practical issues.
Process Chemistry in the Pharmaceutical Industry by Daniel Fishman — last modified 02-13-08 01:15 PM: New conference chairs Pat Confalone of DuPont and Joseph Fortunak of Howard University have developed the 2008 program for the “Process Chemistry in the Pharmaceutical Industry” conference with an emphasis on process R&D and a look into how another industry navigates the issues of commercial ramp up and manufacturing. A number of case studies from the pharmaceutical industry will be given to highlight the challenges and rewards of discovering and developing commercial manufacturing processes for novel therapeutics. The engineering aspects of process R&D, including kinetics, process parameters, process analytical technology, and green chemistry, will also be explored. A half-day will be devoted to presentations from the crop protection sector, where cost of goods is a critical success factor, and practitioners must develop commercial processes within severe cost constraints in the face of complex active ingredient targets. This requires highly convergent syntheses with starting material pricing less than $ 10 / kg, often eliminating several excellent alternative routes for the manufacturing process. Many of the insights from the Agrichemicals industry should prove beneficial to pharmaceutical Process R&D organizations. Though the focus of the conference is on process chemistry currently in practice in industry, as always, noted academics will present their ideas and work on important novel methodologies that will impact process R&D capabilities in the near future.
PK/PD for Medicinal Chemists by Daniel Fishman — last modified 02-13-08 01:06 PM: Conference chairs Zheng Yang of Bristol-Myers Squibb and Ellen Q. Wang of Pfizer will present the 3rd annual ACS ProSpectives conference on pharmacokinetics (PK) and pharmacodynamics (PD). This conference is specifically designed for medicinal chemists and team leaders directly involved in the discovery and early development of new drugs who want to learn more about PK-PD and applying it to drug design. The 2-day conference will move from the basic concepts and principles of PK-PD to the application of these concepts to drug discovery programs from various therapeutic areas, including,  Neuroscience  Oncology  Immunology  Metabolic diseases Each session will be highlighted with a case study from the medicinal chemistry perspective that demonstrates the value of understanding PK-PD relationships in the design of better drug molecules.
Mechanisms of Chemically-Induced Toxicity for Medicinal Chemistry by Daniel Fishman —

Sections

Personal tools

Document Actions

Events

Sections

Personal tools

Local resources

External links

Document Actions

Events